View Filing Data

$ 3,633

$ 4,140

265

258

2,891

2,068

3,000

2,889

Other current assets

156

140

Total current assets

9,945

9,495

Equity method investments

^[1]

589

414

1,364

Deferred tax assets

679

657

19,098

14,686

Intangible assets, net

425

464

Goodwill

1,190

104

Accounts payable and accrued expenses

391

356

Total assets

32,355

27,540

Liabilities and equity

3,801

3,879

Deferred income

289

200

Total current liabilities

1,117

756

5,207

4,835

Other noncurrent liabilities

11,308

9,154

677

623

Total liabilities

17,192

14,612

Commitments and contingencies

Redeemable convertible notes

Micron shareholders' equity

Common stock, $0.10 par value, 3,000 shares authorized, 1,110 shares issued and 1,106 outstanding (1,094 issued and 1,040 outstanding as of September 1, 2016)

111

109

Additional capital

8,003

7,736

Retained earnings

6,247

5,299

Treasury stock, 4 shares held (54 as of September 1, 2016)

(67)

(1,029)

Accumulated other comprehensive (loss)

(7)

(35)

Total Micron shareholders' equity

14,287

12,080

Noncontrolling interests in subsidiaries

848

Total equity

15,135

12,928

Total liabilities and equity

$ 32,355

$ 27,540

[1]	The maturities of long-term marketable investments range from one to four years.

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares shares in Millions	Mar. 02, 2017	Sep. 01, 2016
Liabilities and equity
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common Stock, authorized shares (in shares)	3,000	3,000
Common Stock, issued (in shares)	1,110	1,094
Common Stock, outstanding (in shares)	1,106	1,040
Treasury Stock, held (in shares)	4	54

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Mar. 02, 2017	Mar. 03, 2016
Cash flows from operating activities
Net income	$ 1,074	$ 110
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation expense and amortization of intangible assets	1,774	1,511
Amortization of debt discount and other costs	63	64
Stock-based compensation	101	101
Gain on remeasurement of previously-held equity interest in Inotera	(71)	0
Equity in net (income) loss of equity method investees	(5)	(64)
Change in operating assets and liabilities
Receivables	(773)	542
Inventories	174	(268)
Accounts payable and accrued expenses	399	(67)
Payments attributed to intercompany balances with Inotera	(361)	0
Deferred income taxes, net	59	(27)
Other	109	(19)
Net cash provided by operating activities	2,543	1,883
Cash flows from investing activities
Acquisition of Inotera	(2,634)	0
Expenditures for property, plant, and equipment	(2,428)	(2,209)
Purchases of available-for-sale securities	(803)	(679)
Payments to settle hedging activities	(249)	(66)
Proceeds from sales and maturities of available-for-sale securities	620	1,950
Proceeds from settlement of hedging activities	74	114
Other	54	(136)
Net cash provided by (used for) investing activities	(5,366)	(1,026)
Cash flows from financing activities
Proceeds from issuance of debt	2,961	174
Proceeds from issuance of stock under equity plans	68	24
Proceeds from equipment sale-leaseback transactions	0	424
Repayments of debt	(556)	(519)
Payments on equipment purchase contracts	(33)	(14)
Cash paid to acquire treasury stock	(33)	(147)
Other	(66)	(10)
Net cash provided by (used for) financing activities	2,341	(68)
Effect of changes in currency exchange rates on cash and equivalents	(25)	2
Net increase (decrease) in cash and equivalents	(507)	791
Cash and equivalents at beginning of period	4,140	2,287
Cash and equivalents at end of period	$ 3,633	$ 3,078

Business and Basis of Presentation	6 Months Ended
Business and Basis of Presentation	Mar. 02, 2017
Accounting Policies [Abstract]
Business and Basis of Presentation	Business and Basis of Presentation We are a world leader in innovative memory solutions. Through our global brands – Micron^®, Crucial^®, Lexar^®, and Ballistix^® – our broad portfolio of high-performance memory technologies, including DRAM, NAND Flash, NOR Flash, and 3D XPoint™ memory, is transforming how the world uses information. Backed by more than 35 years of technology leadership, our memory solutions enable the world's most innovative computing, consumer, enterprise storage, data center, mobile, embedded, and automotive applications. The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended September 1, 2016. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, consisting of a normal recurring nature, to fairly state the financial information set forth herein. Certain reclassifications have been made to prior period amounts to conform to current period presentation. Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2017 and 2016 each contain 52 weeks. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended September 1, 2016.

Variable Interest Entities	6 Months Ended
Variable Interest Entities	Mar. 02, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	Variable Interest Entities We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments. Unconsolidated VIEs Inotera: Prior to our acquisition of the remaining interest in Inotera on December 6, 2016, Inotera was a VIE because of the terms of its supply agreement with us. We had determined that we did not have the power to direct the activities of Inotera that most significantly impacted its economic performance, primarily due to limitations on our governance rights that required the consent of other parties for key operating decisions and due to Inotera's dependence on Nanya for financing and the ability of Inotera to operate in Taiwan. Therefore, we did not consolidate Inotera and we accounted for our interest under the equity method. (See "Acquisition of Inotera" and "Equity Method Investments – Inotera" notes.) EQUVO: EQUVO HK Limited ("EQUVO"), a special purpose entity, was created to facilitate an equipment sale-leaseback financing transaction between us and a consortium of financial institutions. Neither we nor the financing entities have an equity interest in EQUVO. EQUVO was a VIE because its equity was not sufficient to permit it to finance its activities without additional support from the financing entities and because the third-party equity holder lacked characteristics of a controlling financial interest. By design, the arrangement with EQUVO was merely a financing vehicle and we did not bear any significant risks from variable interests with EQUVO. Therefore, we had determined that we did not have the power to direct the activities of EQUVO that most significantly impact its economic performance and we did not consolidate EQUVO. In February 2017, we completed all of our obligations under the sale-leaseback financing and no longer have any variable interests in EQUVO. SC Hiroshima Energy Corporation: SC Hiroshima Energy Corporation ("SCHE") is an entity created to construct and operate a cogeneration, electrical power plant to support our wafer manufacturing facility in Hiroshima, Japan. We do not have an equity interest in SCHE. SCHE is a VIE due to the nature of its tolling agreements with us and our option to purchase SCHE's assets. We do not control the operation and maintenance of the plant, which we have determined are the activities of SCHE that most significantly impact its economic performance. Therefore, we do not consolidate SCHE. PTI Xi'an: Powertech Technology Inc. Xi'an ("PTI Xi'an") is a wholly-owned subsidiary of Powertech Technology Inc. ("PTI") and was created to provide assembly services to us at our manufacturing site in Xi'an, China. We do not have an equity interest in PTI Xi'an. PTI Xi'an is a VIE because of the terms of its service agreement with us and its dependency on PTI to finance its operations. We have determined that we do not have the power to direct the activities of PTI Xi'an that most significantly impact its economic performance, primarily because we have no governance rights. Therefore, we do not consolidate PTI Xi'an. Consolidated VIE IMFT: IMFT is a VIE because all of its costs are passed to us and its other member, Intel, through product purchase agreements and because IMFT is dependent upon us or Intel for additional cash requirements. The primary activities of IMFT are driven by the constant introduction of product and process technology. Because we perform a significant majority of the technology development, we have the power to direct its key activities. In addition, IMFT manufactures certain products exclusively for us using our technology. We consolidate IMFT because we have the power to direct the activities of IMFT that most significantly impact its economic performance and because we have the obligation to absorb losses and the right to receive benefits from IMFT that could potentially be significant to it. (See "Equity – Noncontrolling Interests in Subsidiaries – IMFT" note.)

Recently Adopted Accounting Standards	6 Months Ended
Recently Adopted Accounting Standards	Mar. 02, 2017
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently Adopted Accounting Standards	Recently Adopted Accounting Standards In March 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-09 – Improvements to Employee Share-Based Payment Accounting, which simplified several aspects of the accounting for share-based payment transactions, including income tax consequences, classification of awards as either equity or liabilities, forfeitures, and classification within the statement of cash flows. We adopted this ASU as of the beginning of the first quarter of 2017 and elected to account for forfeitures when they occur, on a modified retrospective basis. As a result of the adoption of this ASU, in the first quarter of 2017, we recognized deferred tax assets of $325 million for the excess tax benefits that arose directly from tax deductions related to equity compensation greater than amounts recognized for financial reporting and also recognized an increase of an equal amount in the valuation allowance against those deferred tax assets. The adoption did not have any other material impacts on our financial statements. In April 2015, the FASB issued ASU 2015-05 – Customer's Accounting for Fees Paid in a Cloud Computing Arrangement, which provided additional guidance to customers about whether a cloud computing arrangement included a software license. Under ASU 2015-05, cloud computing arrangements that contain a software license should be accounted for in a manner consistent with the acquisition of other software licenses, otherwise customers should account for the arrangement as a service contract. ASU 2015-05 also removed the requirement to analogize to ASC 840-10 – Leases, to determine the asset acquired in a software licensing arrangement. We adopted this ASU as of the beginning of the first quarter of 2017 on a prospective basis. The adoption of this ASU did not have a material impact on our financial statements. In February 2015, the FASB issued ASU 2015-02 – Amendments to the Consolidation Analysis, which amended the consolidation requirements in Accounting Standards Codification 810 – Consolidation. ASU 2015-02 made targeted amendments to the consolidation guidance for VIEs. We adopted this ASU as of the beginning of the first quarter of 2017 under a modified-retrospective approach. The adoption of this ASU did not have an impact on our financial statements.

The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6507316

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Direct Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=66092750

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Indirect Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.10-01.(b)(6))
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Accounting Change
-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Retrospective Application
-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305

Recently Issued Accounting Standards	6 Months Ended
Recently Issued Accounting Standards	Mar. 02, 2017
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently Issued Accounting Standards	Recently Issued Accounting Standards In January 2017, the FASB issued ASU 2017-04 – Simplifying the Test for Goodwill Impairment, which modifies the goodwill impairment test and requires an entity to write down the carrying value of goodwill up to the amount by which the carrying amount of a reporting unit exceeds its fair value. This ASU will be effective for us beginning in the first quarter of 2021 with early adoption permitted and requires prospective adoption. We expect to adopt this ASU in the fourth quarter of 2017. Since the ASU simplifies the test for goodwill impairment, we do not expect the adoption of the ASU itself to have a material impact on our financial statements. In November 2016, the FASB issued ASU 2016-18 – Restricted Cash, which requires amounts generally described as restricted cash and restricted cash equivalents be included with cash and cash equivalents when reconciling the total beginning and ending amounts for the periods shown on the statement of cash flows. This ASU will be effective for us beginning in the first quarter of 2019 with early adoption permitted and requires retrospective adoption. We are evaluating the timing and effects of our adoption of this ASU on our financial statements. In October 2016, the FASB issued ASU 2016-16 – Intra-Entity Transfers Other Than Inventory, which requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. This ASU will be effective for us beginning in the first quarter of 2019 with early adoption permitted and requires modified retrospective adoption. We are evaluating the timing and effects of our adoption of this ASU on our financial statements. In June 2016, the FASB issued ASU 2016-13 – Measurement of Credit Losses on Financial Instruments, which requires a financial asset (or a group of financial assets) measured on the basis of amortized cost to be presented at the net amount expected to be collected. This ASU requires that the income statement reflect the measurement of credit losses for newly recognized financial assets as well as the expected increases or decreases of expected credit losses that have taken place during the period. This ASU requires that credit losses of debt securities designated as available-for-sale be recorded through an allowance for credit losses and limits the credit loss to the amount by which fair value is below amortized cost. We are required to adopt this ASU beginning in the first quarter of 2021; however, we are permitted to adopt this ASU as early as the first quarter of 2020. This ASU is required to be adopted using a modified retrospective approach, with prospective adoption for debt securities for which an other-than-temporary impairment had been recognized before the effective date. We are evaluating the timing and effects of our adoption of this ASU on our financial statements. In February 2016, the FASB issued ASU 2016-02 – Leases, which amends a number of aspects of lease accounting, including requiring lessees to recognize operating leases with a term greater than one year on their balance sheet as a right-of-use asset and corresponding liability, measured at the present value of the lease payments. This ASU will be effective for us beginning in the first quarter of 2020 with early adoption permitted and is required to be adopted using a modified retrospective approach. The adoption of this ASU will result in an increase to our consolidated balance sheets for these right-of-use assets and corresponding liabilities. We are evaluating the timing and other effects of our adoption of this ASU on our financial statements. In January 2016, the FASB issued ASU 2016-01 – Recognition and Measurement of Financial Assets and Financial Liabilities, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. This ASU will be effective for us beginning in the first quarter of 2019 and requires modified retrospective adoption. We are evaluating the effects of our adoption of this ASU on our financial statements. In May 2014, the FASB issued ASU 2014-09 – Revenue from Contracts with Customers, which supersedes nearly all existing revenue recognition guidance under generally accepted accounting principles in the U.S. The core principal of this ASU, as amended, is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. We are required to adopt this ASU beginning in our the quarter of 2019; however, we are permitted to adopt this ASU as early as the first quarter of 2018. This ASU allows for either full retrospective or modified retrospective adoption. We expect that, as a result of the adoption of this ASU, the timing of recognizing revenue from sales of products to our distributors under agreements allowing rights of return or price protection will be generally earlier than under the existing revenue recognition guidance. After adoption, the impact of this change in any reporting period is expected to be the net effect of changes to revenue recognized as of the beginning and end of each period. Revenue recognized upon resale by our customers with these rights was 20% and 22% for the second quarter and first six months of 2017, respectively, and 24% for the second quarter and first six months of 2016. We are evaluating the timing, method, and other effects of our adoption of this ASU on our financial statements.

Acquisition of Inotera

6 Months Ended

Mar. 02, 2017

Inotera

Business Acquisition [Line Items]

Acquisition of Inotera

Through December 6, 2016, we held a 33% ownership interest in Inotera, Nanya and certain of its affiliates held a 32% ownership interest, and the remaining ownership interest was publicly held. On December 6, 2016, we acquired the 67% remaining interest in Inotera not owned by us (the "Inotera Acquisition") and began consolidating Inotera's operating results. The cash paid for the Inotera Acquisition was funded, in part, with proceeds from the 2021 MSTW Term Loan and the sale of shares of our common stock to Nanya. Inotera manufactures DRAM products at its 300mm wafer fabrication facility in Taoyuan City, Taiwan, and sold such products exclusively to us through supply agreements. SG&A expenses for the first six months of 2017 and for full fiscal 2016 included transaction costs of $13 million and $3 million, respectively, incurred in connection with the Inotera Acquisition.

In connection with the Inotera Acquisition, we revalued our previously-held 33% equity interest to its fair value. In determining the fair value, we used various valuation techniques, including the share price of Inotera prior to the announcement of the acquisition and discounted cash flow projections using inputs including discount rate and terminal growth rate (Level 3). As a result, we recognized a non-operating gain of $71 million in the second quarter of 2017.

In connection with the Inotera Acquisition, we sold 58 million shares of our common stock to Nanya (the "Micron Shares") and received cash proceeds of $986 million. Because the sale of the Micron Shares to Nanya was contemporaneously contemplated with, and contingent upon, the closing the Inotera Acquisition, the issuance of the Micron Shares was treated in purchase accounting as a non-cash exchange for a portion of the shares of Inotera held by Nanya. The Micron Shares were issued in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended, and are subject to certain restrictions on transfers. To reflect the lack of transferability, the fair value of the Micron Shares based on the trading price of our common stock on the acquisition date was reduced by a discount of $81 million, which was determined based on the implied volatility derived from traded options on our stock and on the duration of the lack of transferability (Level 2).

We estimated the assets acquired and liabilities assumed of Inotera as of the December 6, 2016 acquisition date. These estimates could change as additional information becomes available. The consideration and provisional valuation of assets acquired and liabilities assumed are as follows:



Consideration
Cash paid for Inotera Acquisition	$	4,099
Less cash received from selling Micron Shares	(986		)
Net cash paid for Inotera Acquisition	3,113
Fair value of our previously-held equity interest in Inotera	1,441
Fair value of Micron Shares exchanged for Inotera shares	995
Other	3
Payments attributed to intercompany balances with Inotera	(361		)
	$	5,191

Assets acquired and liabilities assumed
Cash and equivalents	$	118
Inventories	285
Other current assets	27
Property, plant, and equipment	3,781
Deferred tax assets	74
Goodwill	1,086
Other noncurrent assets	117
Accounts payable and accrued expenses	(232		)
Debt	(56		)
Other noncurrent liabilities	(9		)
	$	5,191

As a result of the Inotera Acquisition, we expect to experience greater operational flexibility to drive new technology in products manufactured by Inotera, optimize the deployment of our cash flows across our operations, and enhance our ability to adapt our product offerings to changes in market conditions. We are evaluating the assignment of goodwill to our reporting units. Goodwill resulting from the Inotera Acquisition is not deductible for Taiwan corporate income tax purposes; however, it is deductible for Taiwan surtax purposes.

Unaudited Pro Forma Financial Information

The following unaudited pro forma financial information presents the combined results of operations as if the Inotera Acquisition had occurred on September 4, 2015. The pro forma financial information includes the accounting effects of the business combination, including adjustments for depreciation of property, plant, and equipment, interest expense, elimination of intercompany activities, and revaluation of inventories. The unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Inotera Acquisition occurred on September 4, 2015.



	Quarter ended					Six months ended
	March 2, 2017		March 3, 2016			March 2, 2017		March 3, 2016
Net sales	$	4,648	$	2,927		$	8,613	$	6,272
Net income (loss)	890		(196		)	1,080		(48		)
Net income (loss) attributable to Micron	890		(197		)	1,080		(49		)
Earnings (loss) per share
Basic	0.81		(0.18		)	0.98		(0.04		)
Diluted	0.77		(0.18		)	0.93		(0.04		)

The unaudited pro forma financial information for 2017 includes our results for the quarter and six months ended March 2, 2017 (which includes the results of Inotera since our acquisition of Inotera on December 6, 2016), the results of Inotera for the three months ended November 30, 2016, and the adjustments described above. The pro forma information for 2016 includes our results for the quarter and six months ended March 3, 2016, the results of Inotera for the quarter and six months ended February 28, 2016, and the adjustments described above.

Technology Transfer and License Agreements with Nanya

Effective December 6, 2016, under the terms of technology transfer and license agreements, Nanya has options to require us to transfer to Nanya for Nanya's use certain technology and deliverables related to the next DRAM process node generation after our 20nm process node (the "1X Process Node") and the next DRAM process node generation after the 1X Process Node. Under the terms of the agreements, Nanya would pay royalties to us for a license to the transferred technologies based on revenues from products utilizing the technologies, subject to specified caps, and we would also receive an equity interest in Nanya upon the achievement of certain milestones.

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1524-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4922-128472

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4934-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4926-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=73530397&loc=SL65897772-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

Cash and Investments

6 Months Ended

Mar. 02, 2017

Investments [Abstract]

Cash and Investments

Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	March 2, 2017								September 1, 2016
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	2,744	$	—	$	—	$	2,744	$	2,258	$	—	$	—	$	2,258
Level 1⁽²⁾
Money market funds	306		—		—		306		1,507		—		—		1,507
Level 2⁽³⁾
Certificates of deposit	456		9		8		473		373		33		—		406
Corporate bonds	13		120		300		433		—		142		235		377
Government securities	24		76		106		206		2		62		82		146
Asset-backed securities	—		2		175		177		—		12		97		109
Commercial paper	90		58		—		148		—		9		—		9
	$	3,633	$	265	$	589	$	4,487	$	4,140	$	258	$	414	$	4,812


⁽¹⁾	The maturities of long-term marketable investments range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾

The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to such pricing information as of March 2, 2017.

Proceeds from sales of available-for-sale securities were $36 million and $548 million for the second quarter and first six months of 2017, respectively, and $585 million and $992 million for the second quarter and first six months of 2016, respectively. Gross realized gains and losses from sales of available-for-sale securities were not material for any period presented. As of March 2, 2017, there were no available-for-sale securities that had been in a loss position for longer than 12 months.

Other noncurrent assets, excluded from the table above, included restricted cash of $97 million and $122 million as of March 2, 2017 and September 1, 2016, respectively.

Receivables

6 Months Ended

Mar. 02, 2017

Receivables [Abstract]



As of	March 2, 2017		September 1, 2016
Trade receivables	$	2,528	$	1,765
Income and other taxes	125		119
Other	238		184
	$	2,891	$	2,068

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

Inventories

6 Months Ended

Mar. 02, 2017

Inventory Disclosure [Abstract]

Property, Plant and Equipment [Abstract]



As of	March 2, 2017		September 1, 2016
Finished goods	$	862	$	899
Work in process	1,833		1,761
Raw materials and supplies	305		229
	$	3,000	$	2,889

Property, Plant, and Equipment

6 Months Ended

Mar. 02, 2017

Property, Plant, and Equipment



As of	September 1, 2016			Additions			Retirements and Other			March 2, 2017
Land	$	145		$	205		$	(2	)	$	348
Buildings	6,653			785			(12		)	7,426
Equipment⁽¹⁾	25,910			5,170			(254		)	30,826
Construction in progress⁽²⁾	475			(18		)	3			460
Software	422			11			(2		)	431
	33,605			6,153			(267		)	39,491
Accumulated depreciation	(18,919		)	(1,720		)	246			(20,393		)
	$	14,686		$	4,433		$	(21	)	$	19,098


⁽¹⁾	Included costs related to equipment not placed into service of $956 million and $1.47 billion as of March 2, 2017 and September 1, 2016, respectively.


⁽²⁾	Included building-related construction and tool installation costs for assets not placed into service.

Depreciation expense was $976 million and $1.72 billion for the second quarter and first six months of 2017, respectively, and $745 million and $1.45 billion for the second quarter and first six months of 2016, respectively. In the fourth quarter of 2016, we revised the estimated useful lives of equipment in our DRAM wafer fabrication facilities from five to seven years, which reduced depreciation costs by approximately $100 million per quarter in 2017.

Equity Method Investments

6 Months Ended

Mar. 02, 2017

Equity Method Investments and Joint Ventures [Abstract]

Equity Method Investments



As of	March 2, 2017				September 1, 2016
	Investment Balance		Ownership Percentage		Investment Balance		Ownership Percentage
Inotera	$	—	—	%	$	1,314	33	%
Tera Probe	23		40	%	36		40	%
Other	15		Various		14		Various
	$	38			$	1,364

Equity in net income (loss) of equity method investees, net of tax, included the following:



	Quarter ended				Six months ended
	March 2, 2017		March 3, 2016		March 2, 2017			March 3, 2016
Inotera	$	—	$	2	$	9		$	54
Tera Probe	7		3		(5		)	6
Other	—		—		1			4
	$	7	$	5	$	5		$	64

Inotera

Through December 6, 2016, we partnered with Nanya in Inotera, a Taiwan DRAM memory company, at which time we acquired the remaining 67% interest in Inotera. Historically, we accounted for our interest in Inotera on a two-month lag under the equity method. As a result of the Inotera Acquisition, we account for Inotera without a lag, consistent with our other wholly-owned subsidiaries.

From January 2013 through December 2015, we purchased all of Inotera's DRAM output under supply agreements at prices reflecting discounts from market prices for our comparable components. After December 2015 and until our acquisition of the remaining interest in Inotera, the price for DRAM products purchased by us was based on a formula that equally shared margin between Inotera and us. We purchased $504 million of DRAM products from Inotera in the first quarter of 2017 and $326 million and $705 million in the second quarter and first six months of 2016, respectively.

Tera Probe

We have a 40% interest in Tera Probe, which provides semiconductor wafer testing and probe services to us and others. In the first quarter of 2017, we recorded an impairment charge of $16 million within equity in net income (loss) of equity method investees to write down the carrying value of our investment in Tera Probe to its fair value based on its trading price (Level 1). As of March 2, 2017, our proportionate share of Tera Probe's underlying equity exceeded our investment balance by $47 million, which is expected to be accreted to earnings over a weighted-average period of seven years. We incurred manufacturing costs for services performed by Tera Probe for us of $16 million and $32 million in the second quarter and first six months of 2017, respectively, and $18 million and $39 million in the second quarter and first six months of 2016, respectively.

Intangible Assets and Goodwill

6 Months Ended

Mar. 02, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets and Goodwill



As of	March 2, 2017					September 1, 2016
	Gross Amount		Accumulated Amortization			Gross Amount		Accumulated Amortization
Amortizing assets
Product and process technology	$	755	$	(439	)	$	757	$	(402	)
Other	1		—			1		—
	756		(439		)	758		(402		)
Non-amortizing assets
In-process R&D	108		—			108		—

Total intangible assets	$	864	$	(439	)	$	866	$	(402	)

Goodwill	$	1,190				$	104

During the first six months of 2017 and 2016, we capitalized $14 million and $16 million, respectively, for product and process technology with weighted-average useful lives of ten years. Amortization expense was $27 million and $54 million for the second quarter and first six months of 2017, respectively, and $29 million and $60 million for the second quarter and first six months of 2016, respectively. Expected amortization expense is $55 million for the remainder of 2017, $95 million for 2018, $47 million for 2019, $31 million for 2020, and $27 million for 2021.

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

Accounts Payable and Accrued Expenses

Accounts Payable and Accrued Expenses

6 Months Ended

Mar. 02, 2017

Payables and Accruals [Abstract]



As of	March 2, 2017		September 1, 2016
Accounts payable	$	1,380	$	1,186
Property, plant, and equipment payables	1,378		1,649
Salaries, wages, and benefits	447		289
Customer advances	153		132
Income and other taxes	117		41
Related party payables	7		273
Other	319		309
	$	3,801	$	3,879

As of September 1, 2016, related party payables included $266 million due to Inotera primarily for the purchase of DRAM products.

Debt

6 Months Ended

Mar. 02, 2017

Debt Disclosure [Abstract]

Debt



As of	March 2, 2017										September 1, 2016
	Stated Rate		Effective Rate		Current		Long-Term		Total		Current		Long-Term		Total
MMJ creditor installment payments	N/A		6.52	%	$	148	$	446	$	594	$	189	$	680	$	869
Capital lease obligations	N/A		3.42	%	349		914		1,263		380		1,026		1,406
2021 MSAC senior secured term loan	3.464	%	3.87	%	—		445		445		—		—		—
2021 MSTW senior secured term loan	2.852	%	3.02	%	—		2,584		2,584		—		—		—
2022 senior notes	5.875	%	6.14	%	—		591		591		—		590		590
2022 senior secured term loan B	4.540	%	4.95	%	5		728		733		5		730		735
2023 senior notes	5.250	%	5.43	%	—		990		990		—		990		990
2023 senior secured notes	7.500	%	7.69	%	—		1,238		1,238		—		1,237		1,237
2024 senior notes	5.250	%	5.38	%	—		546		546		—		546		546
2025 senior notes	5.500	%	5.56	%	—		1,140		1,140		—		1,139		1,139
2026 senior notes	5.625	%	5.73	%	—		446		446		—		446		446
2032C convertible senior notes⁽¹⁾	2.375	%	5.95	%	—		207		207		—		204		204
2032D convertible senior notes⁽¹⁾	3.125	%	6.33	%	—		156		156		—		154		154
2033E convertible senior notes⁽¹⁾	1.625	%	4.50	%	171		—		171		—		168		168
2033F convertible senior notes⁽¹⁾	2.125	%	4.93	%	274		—		274		—		271		271
2043G convertible senior notes	3.000	%	6.76	%	—		664		664		—		657		657
Other notes payable	2.189	%	2.59	%	170		213		383		182		316		498
					$	1,117	$	11,308	$	12,425	$	756	$	9,154	$	9,910

⁽¹⁾

Since the closing price of our common stock exceeded 130% of the conversion price per share for at least 20 trading days in the 30 trading day period ended on December 31, 2016, these notes are convertible by the holders through the calendar quarter ending March 31, 2017. The 2033 Notes were classified as current as of March 2, 2017 because the terms of these notes require us to pay cash for the principal amount of any converted notes and holders of these notes had the right to convert their notes as of that date.

Capital Lease Obligations

In the second quarter of 2017, we recorded capital lease obligations aggregating $82 million at a weighted-average effective interest rate of 2.9% and a weighted-average expected term of 7 years. In the first six months of 2017, we recorded capital lease obligations aggregating $133 million.

2021 MSAC Senior Secured Term Loan

In November 2016, we entered into a five-year variable-rate facility agreement to obtain up to $800 million of financing, collateralized by certain production equipment. On December 2, 2016, we drew $450 million under the 2021 MSAC Term Loan and may utilize the remaining facility in multiple draws until June 10, 2017. Interest is payable quarterly at a per annum rate equal to three-month LIBOR plus 2.4%. Principal is payable in 16 equal quarterly installments beginning in March 2018. The 2021 MSAC Term Loan contains covenants which are customary for financings of this type, including negative covenants that limit or restrict our ability to create liens or dispose of the equipment securing the facility agreement. The 2021 MSAC Term Loan also contains a covenant that the ratio of the outstanding loan to the fair value of the equipment collateralizing the loan not exceed 0.8. If such ratio is exceeded, we are required to grant a security interest in additional equipment and/or prepay the 2021 MSAC Term Loan in an amount sufficient to reduce such ratio to 0.8 or less. The 2021 MSAC Term Loan also contains customary events of default which could result in the acceleration of all amounts to be immediately due and payable and cancellation of all commitments under the facility agreement. The 2021 MSAC Term Loan is guaranteed by Micron.

2021 MSTW Senior Secured Term Loan

In connection with the Inotera Acquisition, on December 6, 2016, we drew 80 billion New Taiwan dollars (equivalent to $2.5 billion) under a collateralized, five-year term loan that bears interest at a variable per annum rate equal to the three-month or six-month TAIBOR, at our option, plus a margin of 2.05%. Principal under the 2021 MSTW Term Loan is payable in six equal semi-annual installments, commencing in June 2019, through December 2021. The 2021 MSTW Term Loan is collateralized by certain assets, including a real estate mortgage on Inotera's main production facility and site, a chattel mortgage over certain equipment of Inotera, all of the stock of our MSTW subsidiary, and the 82% of stock of Inotera owned by MSTW. The 2021 MSTW Term Loan is guaranteed by Micron.

The 2021 MSTW Term Loan contains affirmative and negative covenants, including covenants that limit or restrict our ability to create liens in or dispose of collateral securing obligations under the 2021 MSTW Term Loan, mergers involving MSTW and/or Inotera, loans or guarantees to third parties by Inotera and/or MSTW, and MSTW's and/or Inotera's distribution of cash dividends. The 2021 MSTW Term Loan also contains financial covenants, which are tested semi-annually, as follows:


•	MSTW must maintain a consolidated ratio of total debt to adjusted EBITDA not higher than 5.5x in 2017 and 2018, and not higher than 4.5x in 2019 through 2021;


•	MSTW must maintain adjusted consolidated tangible net worth of not less than 4.0 billion New Taiwan dollars in 2017 and 2018, not less than 6.5 billion New Taiwan dollars in 2019 and 2020, and not less than 12.0 billion New Taiwan dollars in 2021;


•	on a consolidated basis, Micron must maintain a ratio of total debt to adjusted EBITDA not higher than 3.5x in 2017, not higher than 3.0x in 2018 and 2019, and not higher than 2.5x in 2020 and 2021; and


•	on a consolidated basis, Micron must maintain adjusted tangible net worth not less than $9.0 billion in 2017, not less than $12.5 billion in 2018 and 2019, and not less than $16.5 billion in 2020 and 2021.

If MSTW fails to maintain a required financial covenant, the interest rate will be increased by 0.25% until such time as the required financial ratios are maintained. If MSTW's failure continues for two consecutive semi-annual periods, such will constitute an event of default that could result in all obligations owed under the 2021 MSTW Term Loan being accelerated to be immediately due and payable. Micron's failure to maintain a required financial covenant will only result in a 0.25% increase to the interest rate but will not constitute an event of default. The 2021 MSTW Term Loan also contains customary events of default.

Convertible Senior Notes

As of March 2, 2017, the trading price of our common stock was higher than the initial conversion prices of our 2032 Notes and our 2033 Notes. As a result, the conversion values for these notes exceeded the principal amounts by $1.21 billion as of March 2, 2017.

2022 Senior Secured Term Loan B Repricing Amendment

In October 2016, we amended our 2022 Term Loan B, substantially all of which was treated as a debt modification, to reduce the margins added to the base rate from 5.00% to 2.75% and to the adjusted LIBOR rate from 6.00% to 3.75%.

Tender Offers

On March 27, 2017, we commenced tender offers to purchase up to $1.00 billion aggregate purchase price, exclusive of accrued interest (such aggregate purchase price subject to increase by us), of our 2022 senior notes, 2023 senior notes, 2024 senior notes, 2025 senior notes, and 2026 senior notes.

Contingencies	6 Months Ended
Contingencies	Mar. 02, 2017
Loss Contingency [Abstract]
Contingencies	Contingencies We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations, or financial condition. Patent Matters As is typical in the semiconductor and other high-tech industries, from time to time others have asserted, and may in the future assert, that our products or manufacturing processes infringe their intellectual property rights. On November 21, 2014, Elm 3DS Innovations, LLC ("Elm") filed a patent infringement action against Micron, MSP, and Micron Consumer Products Group, Inc. in the U.S. District Court for the District of Delaware. On March 27, 2015, Elm filed an amended complaint against the same entities. The amended complaint alleges that unspecified semiconductor products of ours that incorporate multiple stacked die infringe thirteen U.S. patents and seeks damages, attorneys' fees, and costs. On December 15, 2014, Innovative Memory Solutions, Inc. filed a patent infringement action against Micron in the U.S. District Court for the District of Delaware. The complaint alleges that a variety of our NAND Flash products infringe eight U.S. patents and seeks damages, attorneys' fees, and costs. On June 24, 2016, the President and Fellows of Harvard University filed a patent infringement action against Micron in the U.S. District Court for the District of Massachusetts. The complaint alleges that a variety of our DRAM products infringe two U.S. patents and seeks damages, injunctive relief, and other unspecified relief. Among other things, the above lawsuits pertain to certain of our DDR DRAM, DDR2 DRAM, DDR3 DRAM, DDR4 DRAM, SDR SDRAM, PSRAM, RLDRAM, LPDRAM, NAND Flash, and certain other memory products we manufacture, which account for a significant portion of our net sales. We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations, or financial condition. Qimonda On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda insolvency proceedings, filed suit against Micron and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008 pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera Memories, Inc. (the "Inotera Shares"), representing approximately 18% of Inotera's outstanding shares as of March 2, 2017, and seeks an order requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement. Following a series of hearings with pleadings, arguments, and witnesses on behalf of the Qimonda estate, on March 13, 2014, the Court issued judgments: (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on such shares and all other benefits; (4) denying Qimonda's claims against Micron for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are canceled. In addition, the Court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by it and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by it from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court. We are unable to predict the outcome of the matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera Shares or monetary damages, unspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation, or financial condition. Other In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition.

The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14472-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12021-110248

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14394-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12053-110248

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14453-108349

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14615-108349

Redeemable Convertible Notes	6 Months Ended
Redeemable Convertible Notes	Mar. 02, 2017
Temporary Equity [Abstract]
Redeemable Convertible Notes	Redeemable Convertible Notes Under the terms of the indentures governing the 2033 Notes, upon conversion, we would be required to pay cash equal to the lesser of (1) the aggregate principal amount or (2) the conversion value of the notes being converted. To the extent the conversion value exceeds the principal amount, we could pay cash, shares of common stock, or a combination thereof, at our option, for the amount of such excess. The closing price of our common stock met the thresholds for conversion for the calendar quarter ended December 31, 2016; therefore, the 2033 Notes are convertible by the holders through the calendar quarter ended March 31, 2017. As a result, the 2033 Notes were classified as current debt and the aggregate difference between the principal amount and the carrying value of $28 million was classified as redeemable convertible notes in the accompanying consolidated balance sheet. The closing price of our common stock did not meet the thresholds for the calendar quarter ended June 30, 2016; therefore, the 2033 Notes were not convertible by the holders as of September 1, 2016. Therefore, as of September 1, 2016, the 2033 Notes had been classified as noncurrent debt and the aggregate difference between the principal amount and the carrying value had been classified as additional capital.

Equity

6 Months Ended

Mar. 02, 2017

Equity [Abstract]

Equity

Micron Shareholders' Equity

Treasury Stock: In connection with the Inotera Acquisition, in the second quarter of 2017, we sold 58 million shares of our common stock to Nanya for $986 million in cash, of which 54 million shares were issued from treasury stock. As a result, treasury stock decreased by $1.03 billion, resulting in a decrease in retained earnings of $104 million for the difference between the carrying value of the treasury stock and its $925 million fair value.

Outstanding Capped Calls: Our capped calls are intended to reduce the effect of potential dilution from our convertible notes and provide for our receipt of cash or shares, at our election, from our counterparties if the trading price of our stock is above strike prices on the expiration dates. As of March 2, 2017, the dollar value of cash or shares that we would receive from our outstanding capped calls upon their expiration dates range from $0, if the trading price of our stock is below strike prices for all capped calls at expiration, to $652 million, if the trading price of our stock is at or above the cap prices for all capped calls.

Expiration of Capped Calls: In the second quarter of 2017, we share-settled a portion of our 2032C and 2032D Capped Calls and received 4 million shares of our stock, equal to a value of $67 million, based on the volume-weighted trading stock prices at the expiration dates. The shares received were recorded as treasury stock.

Shareholder Rights Agreement: On January 18, 2017, our shareholders approved a Section 382 Rights Agreement (the "Rights Agreement"), under which our shareholders of record as of the close of business on August 1, 2016 received one right for each share of common stock outstanding, which entitles shareholders to purchase additional shares of our common stock at a significant discount in the event of an ownership change. The Rights Agreement is intended to avoid an ownership change, as defined by Section 382 of the Internal Revenue Code of 1986, as amended, and thereby preserve our current ability to utilize certain net operating loss and credit carryforwards.

Noncontrolling Interests in Subsidiaries



As of	March 2, 2017				September 1, 2016
	Noncontrolling Interest Balance		Noncontrolling Interest Percentage		Noncontrolling Interest Balance		Noncontrolling Interest Percentage
IMFT	$	832	49	%	$	832	49	%
Other	16		Various		16		Various
	$	848			$	848

IMFT: Since IMFT's inception in 2006, we have owned 51% of IMFT, a joint venture between us and Intel that manufactures NAND Flash and 3D XPoint memory products exclusively for the members. The members share the output of IMFT generally in proportion to their investment. IMFT is governed by a Board of Managers for which the number of managers appointed by each member varies based on the members' respective ownership interests. The IMFT joint venture agreement extends through 2024 and includes certain buy-sell rights. Through December 2018, Intel can put to us, and from January 2019 through December 2021, we can call from Intel, Intel's interest in IMFT, in either case, for an amount equal to the noncontrolling interest balance attributable to Intel at such time either member exercises its right. If Intel exercises its put right, we can elect to set the closing date of the transaction to be any time within two years following such election by Intel and can elect to receive financing of the purchase price from Intel for one to two years from the closing date. Creditors of IMFT have recourse only to IMFT's assets and do not have recourse to any other of our assets. In the first six months of 2016, we and Intel contributed $38 million and $37 million, respectively, to IMFT.

IMFT manufactures memory products using designs and technology we develop with Intel. We generally share with Intel the costs of product design and process development activities for NAND Flash and 3D XPoint memory at IMFT and our other facilities. Our R&D expenses were reduced by reimbursements from Intel of $59 million and $115 million for the second quarter and first six months of 2017, respectively, and $53 million and $99 million for the second quarter and first six months of 2016, respectively.

Our sales include Non-Trade Non-Volatile Memory, which primarily consists of products sold to Intel through our IMFT joint venture at long-term negotiated prices approximating cost. Non-Trade Non-Volatile Memory sales to Intel were $158 million and $281 million for the second quarter and first six months of 2017, respectively, and $126 million and $252 million for the second quarter and first six months of 2016, respectively.

The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets:



As of	March 2, 2017		September 1, 2016
Assets
Cash and equivalents	$	94	$	98
Receivables	103		89
Inventories	102		68
Other current assets	6		6
Total current assets	305		261
Property, plant, and equipment, net	1,680		1,792
Other noncurrent assets	42		50
Total assets	$	2,027	$	2,103

Liabilities
Accounts payable and accrued expenses	$	151	$	175
Deferred income	6		7
Current debt	16		16
Total current liabilities	173		198
Long-term debt	37		66
Other noncurrent liabilities	91		94
Total liabilities	$	301	$	358

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Restrictions on Net Assets

As a result of the corporate reorganization proceedings the MMJ Companies initiated in March 2012, and for so long as such proceedings continue, the MMJ Group is subject to certain restrictions on dividends, loans, and advances. In addition, the 2021 MSTW Term Loan contains covenants that limit or restrict the ability of MSTW and/or Inotera to distribute cash dividends. Also, our ability to access the cash and other assets of IMFT through dividends, loans, or advances, including to finance our other operations, is limited and is subject to agreement by Intel. As a result, our total restricted net assets (net assets less intercompany balances and noncontrolling interests) as of March 2, 2017 were $3.38 billion for the MMJ Group, $2.80 billion for MSTW and Inotera, and $894 million for IMFT, which included cash and equivalents of $529 million for the MMJ Group, $297 million for MSTW and Inotera, and $94 million for IMFT.

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Fair Value Measurements

6 Months Ended

Mar. 02, 2017

Fair Value Disclosures [Abstract]

Fair Value Measurements

All of our marketable debt and equity investments (excluding equity method investments) were classified as available-for-sale and carried at fair value. Amounts reported as cash and equivalents, receivables, and accounts payable and accrued expenses approximate fair value. The estimated fair value and carrying value of debt instruments (excluding the carrying value of the equity and mezzanine equity components of our convertible notes) were as follows:



As of	March 2, 2017				September 1, 2016
	Fair Value		Carrying Value		Fair Value		Carrying Value
Notes and MMJ creditor installment payments	$	10,092	$	9,690	$	7,257	$	7,050
Convertible notes	3,191		1,472		2,408		1,454

The fair values of our convertible notes were determined based on inputs that were observable in the market or that could be derived from, or corroborated with, observable market data, including the trading price of our convertible notes when available, our stock price, and interest rates based on similar debt issued by parties with credit ratings similar to ours (Level 2). The fair values of our other debt instruments were estimated based on discounted cash flows using inputs that were observable in the market or that could be derived from, or corroborated with, observable market data, including the trading price of our notes, when available, and interest rates based on similar debt issued by parties with credit ratings similar to ours (Level 2).

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

Derivative Instrument Detail [Abstract]

Derivative Instruments

6 Months Ended

Mar. 02, 2017

Derivative Instruments

We use derivative instruments to manage a portion of our exposure to changes in currency exchange rates from our monetary assets and liabilities denominated in currencies other than the U.S. dollar. We do not use derivative instruments for speculative purpose.

Derivative Instruments without Hedge Accounting Designation

Currency Derivatives: To hedge our exposures of monetary assets and liabilities to changes in currency exchange rates, we generally utilize a rolling hedge strategy with currency forward contracts that mature within 8 months. In addition, to mitigate the risk of the yen strengthening against the U.S. dollar on our MMJ creditor installment payments due in December 2017 and 2018, we entered into forward contracts to purchase 18 billion yen in December 2017 and 28 billion yen in December 2018. At the end of each reporting period, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars and the associated outstanding forward contracts are marked to market. Currency forward contracts are valued at fair values based on the middle of bid and ask prices of dealers or exchange quotations (Level 2). Total notional amounts and gross fair values for derivative instruments without hedge accounting designation were as follows:



	Notional Amount (in U.S. Dollars)		Fair Value
	Notional Amount (in U.S. Dollars)		Current Assets⁽¹⁾		Current Liabilities⁽²⁾			Noncurrent Liabilities⁽³⁾
As of March 2, 2017
New Taiwan dollar	$	2,855	$	57	$	(2	)	$	—
Yen	1,033		—		(12		)	(4		)
Euro	151		—		(1		)	—
Singapore dollar	134		—		(1		)	—
Other	20		—		—			—
	$	4,193	$	57	$	(16	)	$	(4	)
As of September 1, 2016
Yen	$	1,668	$	—	$	(10	)	$	—
Euro	93		—		—			—
Singapore dollar	206		—		—			—
Other	85		—		(1		)	—
	$	2,052	$	—	$	(11	)	$	—


⁽¹⁾	Included in receivables – other.


⁽²⁾	Included in accounts payable and accrued expenses – other.


⁽³⁾	Included in other noncurrent liabilities.

Realized and unrealized gains and losses on derivative instruments without hedge accounting designation as well as the change in the underlying monetary assets and liabilities due to changes in currency exchange rates are included in other non-operating income (expense), net. For derivative instruments without hedge accounting designation, we recognized net gains of $61 million and net losses of $117 million for the second quarter and first six months of 2017, respectively, and net gains of $92 million and $71 million for the second quarter and first six months of 2016, respectively.

Derivative Instruments with Cash Flow Hedge Accounting Designation

Currency Derivatives: We utilize currency forward contracts that generally mature within 12 months to hedge our exposure to changes in cash flows from changes in currency exchange rates for certain capital expenditures. Currency forward contracts are measured at fair value based on market-based observable inputs including currency exchange spot and forward rates, interest rates, and credit-risk spreads (Level 2).

For derivative instruments designated as cash flow hedges, the effective portion of the realized and unrealized gain or loss on the derivatives is included as a component of accumulated other comprehensive income (loss). Amounts in accumulated other comprehensive income (loss) are reclassified into earnings in the same line items and in the same periods in which the underlying transactions affect earnings. The ineffective and excluded portion of the realized and unrealized gain or loss is included in other non-operating income (expense), net. Total notional amounts and gross fair values for derivative instruments with cash flow hedge accounting designation were as follows:



	Notional Amount (in U.S. Dollars)		Fair Value
	Notional Amount (in U.S. Dollars)		Current Assets⁽¹⁾		Current Liabilities⁽²⁾
As of March 2, 2017
Yen	$	6	$	—	$	—
Euro	6		—		—
	$	12	$	—	$	—
As of September 1, 2016
Yen	$	107	$	2	$	(1	)
Euro	65		—		(1		)
	$	172	$	2	$	(2	)


⁽¹⁾	Included in receivables – other.


⁽²⁾	Included in accounts payable and accrued expenses – other.

We recognized losses in accumulated other comprehensive income (loss) from the effective portion of cash flow hedges of $9 million in the first six months of 2017, and gains of $5 million and $1 million in the second quarter and first six months of 2016, respectively. Neither the ineffective portions of cash flow hedges recognized in other non-operating income (expense) nor amounts reclassified from accumulated other comprehensive income (loss) to earnings were material in the second quarters and first six months 2017 and 2016. The amount from cash flow hedges included in accumulated other comprehensive income (loss) that is expected to be reclassified into earnings in the next 12 months is not material.

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Equity Plans

6 Months Ended

Mar. 02, 2017

Equity Plans

As of March 2, 2017, 72 million shares were available for future awards under our equity plans.

Stock Options



	Quarter ended						Six months ended
	March 2, 2017			March 3, 2016			March 2, 2017			March 3, 2016
Stock options granted	4			5			6			7
Weighted-average grant-date fair value per share	$	8.37		$	6.59		$	8.15		$	7.01
Average expected life in years	5.5			5.5			5.5			5.5
Weighted-average expected volatility	47		%	47		%	47		%	47		%
Weighted-average risk-free interest rate	1.9		%	1.7		%	1.8		%	1.7		%
Expected dividend yield	0		%	0		%	0		%	0		%

Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")



	Quarter ended				Six months ended
	March 2, 2017		March 3, 2016		March 2, 2017		March 3, 2016
Restricted stock awards granted	5		6		8		9
Weighted-average grant-date fair value per share	$	18.67	$	14.71	$	18.52	$	15.84

Stock-based Compensation Expense



	Quarter ended				Six months ended
	March 2, 2017		March 3, 2016		March 2, 2017		March 3, 2016
Stock-based compensation expense by caption
Cost of goods sold	$	23	$	19	$	42	$	37
Selling, general, and administrative	18		21		33		38
Research and development	14		15		26		26
	$	55	$	55	$	101	$	101

Stock-based compensation expense by type of award
Stock options	$	18	$	22	$	35	$	42
Restricted stock awards	37		33		66		59
	$	55	$	55	$	101	$	101

As of March 2, 2017, $438 million of total unrecognized compensation costs for unvested awards was expected to be recognized through the second quarter of 2021, resulting in a weighted-average period of 1.3 years. Stock-based compensation expense does not reflect significant income tax benefits, which is consistent with our treatment of income or loss from our U.S. operations.

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

Restructuring and Related Activities [Abstract]

Restructure and Asset Impairments

6 Months Ended

Mar. 02, 2017

Restructure and Asset Impairments



	Quarter ended				Six months ended
	March 2, 2017		March 3, 2016		March 2, 2017		March 3, 2016
2016 Restructuring Plan	$	4	$	—	$	33	$	—
Other	—		1		—		16
	$	4	$	1	$	33	$	16

In the fourth quarter of 2016, we initiated a restructure plan in response to business conditions and the need to accelerate focus on our key priorities (the "2016 Restructuring Plan"). The 2016 Restructuring Plan includes the elimination of certain projects and programs, the permanent closure of a number of open headcount requisitions, workforce reductions in certain areas of our business, and other non-headcount related spending reductions. As a result, we incurred charges of $33 million in the first six months of 2017 and $58 million in the fourth quarter of 2016 and do not expect to incur additional material charges. As of March 2, 2017 and September 1, 2016, we had accrued liabilities of $9 million and $24 million, respectively, related to the 2016 Restructuring Plan.

Other Non-Operating Income (Expense), Net

6 Months Ended

Mar. 02, 2017

Other Nonoperating Income (Expense) [Abstract]

Other Non-Operating Income (Expense), Net



	Quarter ended						Six months ended
	March 2, 2017			March 3, 2016			March 2, 2017			March 3, 2016
Loss from changes in currency exchange rates	$	(28	)	$	(5	)	$	(40	)	$	(8	)
Gain on remeasurement of previously-held equity interest in Inotera	71			—			71			—
Other	(9		)	(1		)	(11		)	(2		)
	$	34		$	(6	)	$	20		$	(10	)

Income Taxes

6 Months Ended

Mar. 02, 2017

Income Tax Disclosure [Abstract]

Income Taxes

Our income tax (provision) benefit consisted of the following:



	Quarter ended						Six months ended
	March 2, 2017			March 3, 2016			March 2, 2017			March 3, 2016
Utilization of and other changes in net deferred tax assets of MMJ, MMT, and Inotera	$	(8	)	$	(10	)	$	(21	)	$	(32	)
U.S. valuation allowance release resulting from business acquisition	—			—			—			41
Other, income tax (provision) benefit, primarily other non-U.S. operations	(30		)	5			(48		)	(10		)
	$	(38	)	$	(5	)	$	(69	)	$	(1	)

We have a full valuation allowance for our net deferred tax asset associated with our U.S. operations. The amount of the deferred tax asset considered realizable could be adjusted if significant positive evidence increases. Income taxes on U.S. operations in the second quarters and first six months of 2017 and 2016 were substantially offset by changes in the valuation allowance.

As of the date of the Inotera Acquisition, Inotera's net operating loss carryforward was $654 million, substantially all of which expires on various dates through 2022. In connection with the Inotera Acquisition, we assumed $54 million of uncertain tax positions, of which $26 million was recorded in purchase accounting as a reduction to deferred tax assets. The amounts recorded in purchase accounting primarily related to the surtax treatment of certain purchase accounting adjustments. During the second quarter of 2017, $21 million of the uncertain tax positions assumed in the Inotera Acquisition reached effective settlement with no impact to tax expense or purchase accounting. Although the timing of final resolution is uncertain, the estimated potential reduction in the Inotera unrecognized tax benefits in the next 12 months ranges from $0 to $33 million, including interest and penalties.

We operate in a number of tax jurisdictions, including Singapore and Taiwan, where our earnings are indefinitely reinvested and are taxed at lower effective tax rates than the U.S. statutory rate and in a number of locations outside the U.S., including Singapore, where we have tax incentive arrangements that are conditional, in part, upon meeting certain business operations and employment thresholds. The effect of tax incentive arrangements, which expire in whole or in part at various dates through 2030, reduced our tax provision for the second quarter and first six months 2017 by $132 million (benefitting our diluted earnings per share by $0.11) and $172 million ($0.15 per diluted share), respectively, and were not material for the second quarter or first six months of 2016.

Earnings Per Share

6 Months Ended

Mar. 02, 2017

Earnings Per Share [Abstract]

Earnings Per Share



	Quarter ended					Six months ended
	March 2, 2017		March 3, 2016			March 2, 2017		March 3, 2016
Net income (loss) available to Micron – Basic and Diluted	$	894	$	(97	)	$	1,074	$	109

Weighted-average common shares outstanding – Basic	1,099		1,036			1,070		1,035
Dilutive effect of equity plans and convertible notes	61		—			55		37
Weighted-average common shares outstanding – Diluted	1,160		1,036			1,125		1,072

Earnings (loss) per share
Basic	$	0.81	$	(0.09	)	$	1.00	$	0.11
Diluted	0.77		(0.09		)	0.95		0.10

Antidilutive potential common shares that could dilute basic earnings per share in the future were 60 million and 62 million for the second quarter and first six months of 2017, respectively, and 185 million and 72 million for the second quarter and first six months of 2016, respectively.

Segment Information

6 Months Ended

Mar. 02, 2017

Segment Reporting [Abstract]

Segment Information

Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision maker. We have the following four business units, which are our reportable segments:

Compute and Networking Business Unit ("CNBU"): Includes memory products sold into compute, networking, graphics, and cloud server markets.

Mobile Business Unit ("MBU"): Includes memory products sold into smartphone, tablet, and other mobile-device markets.

Storage Business Unit ("SBU"): Includes memory products sold into enterprise, client, cloud, and removable storage markets. SBU also includes products sold to Intel through our IMFT joint venture.

Embedded Business Unit ("EBU"): Includes memory products sold into automotive, industrial, connected home, and consumer electronics markets.

Certain operating expenses directly associated with the activities of a specific segment are charged to that segment. Other indirect operating expenses (income) are generally allocated to segments based on their respective percentage of cost of goods sold or forecasted wafer production. In the first quarter of 2017, we revised the measure of segment profitability reviewed by our chief operating decision maker and, as a result, certain items are no longer allocated to our business units. Comparative periods have been revised to reflect these changes. Items not allocated are identified in the table below.

We do not identify or report internally our assets (other than goodwill) or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items, or taxes to segments.



	Quarter ended						Six months ended
	March 2, 2017			March 3, 2016			March 2, 2017			March 3, 2016
Net sales
CNBU	$	1,917		$	1,053		$	3,387		$	2,192
MBU	1,082			503			2,114			1,337
SBU	1,041			901			1,901			1,785
EBU	590			460			1,168			939
All Other	18			17			48			31
	$	4,648		$	2,934		$	8,618		$	6,284

Operating income
CNBU	$	736		$	(33	)	$	940		$	7
MBU	170			(10		)	259			138
SBU	71			(3		)	26			(17		)
EBU	193			96			371			217
All Other	7			5			19			8
	1,177			55			1,615			353

Unallocated
Flow-through of Inotera inventory step up	(60		)	—			(60		)	—
Stock-based compensation	(55		)	(55		)	(101		)	(101		)
Restructure and asset impairments	(4		)	(1		)	(33		)	(16		)
Other	(14		)	(4		)	(18		)	(9		)
	(133		)	(60		)	(212		)	(126		)

Operating income (loss)	$	1,044		$	(5	)	$	1,403		$	227

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

Schedule of Inotera Acquisition

Certain Concentrations	6 Months Ended
Certain Concentrations	Mar. 02, 2017
Risks and Uncertainties [Abstract]
Certain Concentrations	Certain Concentrations Customer concentrations included net sales to Apple of 11% and Intel of 10% for the first six months of 2017.

Business and Basis of Presentation (Policies)	6 Months Ended
Business and Basis of Presentation (Policies)	Mar. 02, 2017
Accounting Policies [Abstract]
Basis of Presentation	The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended September 1, 2016. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, consisting of a normal recurring nature, to fairly state the financial information set forth herein.
Reclassifications	Certain reclassifications have been made to prior period amounts to conform to current period presentation.
Fiscal Period	Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2017 and 2016 each contain 52 weeks. All period references are to our fiscal periods unless otherwise indicated

Variable Interest Entities (Policies)	6 Months Ended
Variable Interest Entities (Policies)	Mar. 02, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities	We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments.

Acquisition of Inotera (Tables) - Inotera

6 Months Ended

Mar. 02, 2017

Business Acquisition [Line Items]

The consideration and provisional valuation of assets acquired and liabilities assumed are as follows:



Consideration
Cash paid for Inotera Acquisition	$	4,099
Less cash received from selling Micron Shares	(986		)
Net cash paid for Inotera Acquisition	3,113
Fair value of our previously-held equity interest in Inotera	1,441
Fair value of Micron Shares exchanged for Inotera shares	995
Other	3
Payments attributed to intercompany balances with Inotera	(361		)
	$	5,191

Assets acquired and liabilities assumed
Cash and equivalents	$	118
Inventories	285
Other current assets	27
Property, plant, and equipment	3,781
Deferred tax assets	74
Goodwill	1,086
Other noncurrent assets	117
Accounts payable and accrued expenses	(232		)
Debt	(56		)
Other noncurrent liabilities	(9		)
	$	5,191

Pro Forma Information including Inotera



	Quarter ended					Six months ended
	March 2, 2017		March 3, 2016			March 2, 2017		March 3, 2016
Net sales	$	4,648	$	2,927		$	8,613	$	6,272
Net income (loss)	890		(196		)	1,080		(48		)
Net income (loss) attributable to Micron	890		(197		)	1,080		(49		)
Earnings (loss) per share
Basic	0.81		(0.18		)	0.98		(0.04		)
Diluted	0.77		(0.18		)	0.93		(0.04		)

Cash and Investments (Tables)

6 Months Ended

Mar. 02, 2017

Investments [Abstract]

Cash and equivalents and the fair values of available-for-sale investments

Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:



As of	March 2, 2017								September 1, 2016
	Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value		Cash and Equivalents		Short-term Investments		Long-term Marketable Investments⁽¹⁾		Total Fair Value
Cash	$	2,744	$	—	$	—	$	2,744	$	2,258	$	—	$	—	$	2,258
Level 1⁽²⁾
Money market funds	306		—		—		306		1,507		—		—		1,507
Level 2⁽³⁾
Certificates of deposit	456		9		8		473		373		33		—		406
Corporate bonds	13		120		300		433		—		142		235		377
Government securities	24		76		106		206		2		62		82		146
Asset-backed securities	—		2		175		177		—		12		97		109
Commercial paper	90		58		—		148		—		9		—		9
	$	3,633	$	265	$	589	$	4,487	$	4,140	$	258	$	414	$	4,812


⁽¹⁾	The maturities of long-term marketable investments range from one to four years.


⁽²⁾	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.

⁽³⁾

Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.

Property, Plant and Equipment [Abstract]

Receivables (Tables)

6 Months Ended

Mar. 02, 2017

Receivables [Abstract]

Schedule of Receivables



As of	March 2, 2017		September 1, 2016
Trade receivables	$	2,528	$	1,765
Income and other taxes	125		119
Other	238		184
	$	2,891	$	2,068

Inventories (Tables)

6 Months Ended

Mar. 02, 2017

Inventory Disclosure [Abstract]

Schedule of Inventories



As of	March 2, 2017		September 1, 2016
Finished goods	$	862	$	899
Work in process	1,833		1,761
Raw materials and supplies	305		229
	$	3,000	$	2,889

Property, Plant, and Equipment (Tables)

6 Months Ended

Mar. 02, 2017

Schedule of Property, Plant, and Equipment



As of	September 1, 2016			Additions			Retirements and Other			March 2, 2017
Land	$	145		$	205		$	(2	)	$	348
Buildings	6,653			785			(12		)	7,426
Equipment⁽¹⁾	25,910			5,170			(254		)	30,826
Construction in progress⁽²⁾	475			(18		)	3			460
Software	422			11			(2		)	431
	33,605			6,153			(267		)	39,491
Accumulated depreciation	(18,919		)	(1,720		)	246			(20,393		)
	$	14,686		$	4,433		$	(21	)	$	19,098


⁽¹⁾	Included costs related to equipment not placed into service of $956 million and $1.47 billion as of March 2, 2017 and September 1, 2016, respectively.


⁽²⁾	Included building-related construction and tool installation costs for assets not placed into service.

Equity Method Investments (Tables)

6 Months Ended

Mar. 02, 2017

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Equity Method Investments



As of	March 2, 2017				September 1, 2016
	Investment Balance		Ownership Percentage		Investment Balance		Ownership Percentage
Inotera	$	—	—	%	$	1,314	33	%
Tera Probe	23		40	%	36		40	%
Other	15		Various		14		Various
	$	38			$	1,364

Equity in net income (loss) of equity method investees, net of tax, included the following:



	Quarter ended				Six months ended
	March 2, 2017		March 3, 2016		March 2, 2017			March 3, 2016
Inotera	$	—	$	2	$	9		$	54
Tera Probe	7		3		(5		)	6
Other	—		—		1			4
	$	7	$	5	$	5		$	64

Intangible Assets and Goodwill (Tables)

6 Months Ended

Mar. 02, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets and Goodwill



As of	March 2, 2017					September 1, 2016
	Gross Amount		Accumulated Amortization			Gross Amount		Accumulated Amortization
Amortizing assets
Product and process technology	$	755	$	(439	)	$	757	$	(402	)
Other	1		—			1		—
	756		(439		)	758		(402		)
Non-amortizing assets
In-process R&D	108		—			108		—

Total intangible assets	$	864	$	(439	)	$	866	$	(402	)

Goodwill	$	1,190				$	104

Accounts Payable and Accrued Expenses (Tables)

6 Months Ended

Mar. 02, 2017

Payables and Accruals [Abstract]

Schedule of Accounts Payable And Accrued Expenses



As of	March 2, 2017		September 1, 2016
Accounts payable	$	1,380	$	1,186
Property, plant, and equipment payables	1,378		1,649
Salaries, wages, and benefits	447		289
Customer advances	153		132
Income and other taxes	117		41
Related party payables	7		273
Other	319		309
	$	3,801	$	3,879

Debt (Tables)

6 Months Ended

Mar. 02, 2017

Debt Disclosure [Abstract]

Schedule of Debt



As of	March 2, 2017										September 1, 2016
	Stated Rate		Effective Rate		Current		Long-Term		Total		Current		Long-Term		Total
MMJ creditor installment payments	N/A		6.52	%	$	148	$	446	$	594	$	189	$	680	$	869
Capital lease obligations	N/A		3.42	%	349		914		1,263		380		1,026		1,406
2021 MSAC senior secured term loan	3.464	%	3.87	%	—		445		445		—		—		—
2021 MSTW senior secured term loan	2.852	%	3.02	%	—		2,584		2,584		—		—		—
2022 senior notes	5.875	%	6.14	%	—		591		591		—		590		590
2022 senior secured term loan B	4.540	%	4.95	%	5		728		733		5		730		735
2023 senior notes	5.250	%	5.43	%	—		990		990		—		990		990
2023 senior secured notes	7.500	%	7.69	%	—		1,238		1,238		—		1,237		1,237
2024 senior notes	5.250	%	5.38	%	—		546		546		—		546		546
2025 senior notes	5.500	%	5.56	%	—		1,140		1,140		—		1,139		1,139
2026 senior notes	5.625	%	5.73	%	—		446		446		—		446		446
2032C convertible senior notes⁽¹⁾	2.375	%	5.95	%	—		207		207		—		204		204
2032D convertible senior notes⁽¹⁾	3.125	%	6.33	%	—		156		156		—		154		154
2033E convertible senior notes⁽¹⁾	1.625	%	4.50	%	171		—		171		—		168		168
2033F convertible senior notes⁽¹⁾	2.125	%	4.93	%	274		—		274		—		271		271
2043G convertible senior notes	3.000	%	6.76	%	—		664		664		—		657		657
Other notes payable	2.189	%	2.59	%	170		213		383		182		316		498
					$	1,117	$	11,308	$	12,425	$	756	$	9,154	$	9,910

⁽¹⁾

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644

Variable Interest Entity [Line Items]

Equity (Tables)

6 Months Ended

Mar. 02, 2017

Schedule Of Noncontrolling Interests In Subsidiaries



As of	March 2, 2017				September 1, 2016
	Noncontrolling Interest Balance		Noncontrolling Interest Percentage		Noncontrolling Interest Balance		Noncontrolling Interest Percentage
IMFT	$	832	49	%	$	832	49	%
Other	16		Various		16		Various
	$	848			$	848

IM Flash Technologies, LLC

Variable Interest Entity [Line Items]

Total IM Flash assets and liabilities

The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets:



As of	March 2, 2017		September 1, 2016
Assets
Cash and equivalents	$	94	$	98
Receivables	103		89
Inventories	102		68
Other current assets	6		6
Total current assets	305		261
Property, plant, and equipment, net	1,680		1,792
Other noncurrent assets	42		50
Total assets	$	2,027	$	2,103

Liabilities
Accounts payable and accrued expenses	$	151	$	175
Deferred income	6		7
Current debt	16		16
Total current liabilities	173		198
Long-term debt	37		66
Other noncurrent liabilities	91		94
Total liabilities	$	301	$	358

Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

Estimated fair value and carrying value of debt instruments

Fair Value Measurements (Tables)

6 Months Ended

Mar. 02, 2017

Fair Value Disclosures [Abstract]

The estimated fair value and carrying value of debt instruments (excluding the carrying value of the equity and mezzanine equity components of our convertible notes) were as follows:



As of	March 2, 2017				September 1, 2016
	Fair Value		Carrying Value		Fair Value		Carrying Value
Notes and MMJ creditor installment payments	$	10,092	$	9,690	$	7,257	$	7,050
Convertible notes	3,191		1,472		2,408		1,454

Derivative Instruments (Tables)

6 Months Ended

Mar. 02, 2017

Derivative Instrument Detail [Abstract]

Schedule of Derivative Instruments without Hedge Accounting Designation

Total notional amounts and gross fair values for derivative instruments without hedge accounting designation were as follows:



	Notional Amount (in U.S. Dollars)		Fair Value
	Notional Amount (in U.S. Dollars)		Current Assets⁽¹⁾		Current Liabilities⁽²⁾			Noncurrent Liabilities⁽³⁾
As of March 2, 2017
New Taiwan dollar	$	2,855	$	57	$	(2	)	$	—
Yen	1,033		—		(12		)	(4		)
Euro	151		—		(1		)	—
Singapore dollar	134		—		(1		)	—
Other	20		—		—			—
	$	4,193	$	57	$	(16	)	$	(4	)
As of September 1, 2016
Yen	$	1,668	$	—	$	(10	)	$	—
Euro	93		—		—			—
Singapore dollar	206		—		—			—
Other	85		—		(1		)	—
	$	2,052	$	—	$	(11	)	$	—


⁽¹⁾	Included in receivables – other.


⁽²⁾	Included in accounts payable and accrued expenses – other.


⁽³⁾	Included in other noncurrent liabilities.

Schedule of Derivative Instruments with Cash Flow Hedge Accounting Designation

Total notional amounts and gross fair values for derivative instruments with cash flow hedge accounting designation were as follows:



	Notional Amount (in U.S. Dollars)		Fair Value
	Notional Amount (in U.S. Dollars)		Current Assets⁽¹⁾		Current Liabilities⁽²⁾
As of March 2, 2017
Yen	$	6	$	—	$	—
Euro	6		—		—
	$	12	$	—	$	—
As of September 1, 2016
Yen	$	107	$	2	$	(1	)
Euro	65		—		(1		)
	$	172	$	2	$	(2	)


⁽¹⁾	Included in receivables – other.


⁽²⁾	Included in accounts payable and accrued expenses – other.

Equity Plans (Tables)

6 Months Ended

Mar. 02, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock options granted and assumptions used in Black-Scholes option valuation model



	Quarter ended						Six months ended
	March 2, 2017			March 3, 2016			March 2, 2017			March 3, 2016
Stock options granted	4			5			6			7
Weighted-average grant-date fair value per share	$	8.37		$	6.59		$	8.15		$	7.01
Average expected life in years	5.5			5.5			5.5			5.5
Weighted-average expected volatility	47		%	47		%	47		%	47		%
Weighted-average risk-free interest rate	1.9		%	1.7		%	1.8		%	1.7		%
Expected dividend yield	0		%	0		%	0		%	0		%

Schedule of restricted stock awards activity



	Quarter ended				Six months ended
	March 2, 2017		March 3, 2016		March 2, 2017		March 3, 2016
Restricted stock awards granted	5		6		8		9
Weighted-average grant-date fair value per share	$	18.67	$	14.71	$	18.52	$	15.84

Stock-based compensation expense by caption



	Quarter ended				Six months ended
	March 2, 2017		March 3, 2016		March 2, 2017		March 3, 2016
Stock-based compensation expense by caption
Cost of goods sold	$	23	$	19	$	42	$	37
Selling, general, and administrative	18		21		33		38
Research and development	14		15		26		26
	$	55	$	55	$	101	$	101

Stock-based compensation expense by type of award
Stock options	$	18	$	22	$	35	$	42
Restricted stock awards	37		33		66		59
	$	55	$	55	$	101	$	101

Restructure and Asset Impairments (Tables)

6 Months Ended

Mar. 02, 2017

Restructuring and Related Activities [Abstract]

Schedule of Restructure and Related Costs



	Quarter ended				Six months ended
	March 2, 2017		March 3, 2016		March 2, 2017		March 3, 2016
2016 Restructuring Plan	$	4	$	—	$	33	$	—
Other	—		1		—		16
	$	4	$	1	$	33	$	16

Other Non-Operating Income (Expense), Net (Tables)

6 Months Ended

Mar. 02, 2017

Other Nonoperating Income (Expense) [Abstract]

Schedule of Other Nonoperating Income (Expense), Net



	Quarter ended						Six months ended
	March 2, 2017			March 3, 2016			March 2, 2017			March 3, 2016
Loss from changes in currency exchange rates	$	(28	)	$	(5	)	$	(40	)	$	(8	)
Gain on remeasurement of previously-held equity interest in Inotera	71			—			71			—
Other	(9		)	(1		)	(11		)	(2		)
	$	34		$	(6	)	$	20		$	(10	)

Income Taxes Income Taxes (Tables)

6 Months Ended

Mar. 02, 2017

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax (Expense) Benefit

Our income tax (provision) benefit consisted of the following:



	Quarter ended						Six months ended
	March 2, 2017			March 3, 2016			March 2, 2017			March 3, 2016
Utilization of and other changes in net deferred tax assets of MMJ, MMT, and Inotera	$	(8	)	$	(10	)	$	(21	)	$	(32	)
U.S. valuation allowance release resulting from business acquisition	—			—			—			41
Other, income tax (provision) benefit, primarily other non-U.S. operations	(30		)	5			(48		)	(10		)
	$	(38	)	$	(5	)	$	(69	)	$	(1	)

Earnings Per Share (Tables)

6 Months Ended

Mar. 02, 2017

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Earnings Per Share



	Quarter ended					Six months ended
	March 2, 2017		March 3, 2016			March 2, 2017		March 3, 2016
Net income (loss) available to Micron – Basic and Diluted	$	894	$	(97	)	$	1,074	$	109

Weighted-average common shares outstanding – Basic	1,099		1,036			1,070		1,035
Dilutive effect of equity plans and convertible notes	61		—			55		37
Weighted-average common shares outstanding – Diluted	1,160		1,036			1,125		1,072

Earnings (loss) per share
Basic	$	0.81	$	(0.09	)	$	1.00	$	0.11
Diluted	0.77		(0.09		)	0.95		0.10

Segment Information (Tables)

6 Months Ended

Mar. 02, 2017

Segment Reporting [Abstract]

Schedule of Results by Segment



	Quarter ended						Six months ended
	March 2, 2017			March 3, 2016			March 2, 2017			March 3, 2016
Net sales
CNBU	$	1,917		$	1,053		$	3,387		$	2,192
MBU	1,082			503			2,114			1,337
SBU	1,041			901			1,901			1,785
EBU	590			460			1,168			939
All Other	18			17			48			31
	$	4,648		$	2,934		$	8,618		$	6,284

Operating income
CNBU	$	736		$	(33	)	$	940		$	7
MBU	170			(10		)	259			138
SBU	71			(3		)	26			(17		)
EBU	193			96			371			217
All Other	7			5			19			8
	1,177			55			1,615			353

Unallocated
Flow-through of Inotera inventory step up	(60		)	—			(60		)	—
Stock-based compensation	(55		)	(55		)	(101		)	(101		)
Restructure and asset impairments	(4		)	(1		)	(33		)	(16		)
Other	(14		)	(4		)	(18		)	(9		)
	(133		)	(60		)	(212		)	(126		)

Operating income (loss)	$	1,044		$	(5	)	$	1,403		$	227

Recently Adopted Accounting Standards Recently Adopted Accounting Standards (Details) - New Accounting Pronouncement, Early Adoption, Effect - Accounting Standards Update 2016-09 $ in Millions	3 Months Ended
	Dec. 01, 2016 USD ($)
New Accounting Pronouncement, Early Adoption [Line Items]
Deferred Tax Assets, Increase from ASU adoption	$ 325
DTA Valuation Allowance, Increase from ASU adoption	$ 325

Recently Issued Accounting Standards Recently Issued Accounting Standards (Details)	3 Months Ended		6 Months Ended
	Mar. 02, 2017	Mar. 03, 2016	Mar. 02, 2017	Mar. 03, 2016
ASU 2014-09 \| Scenario, Previously Reported \| Customers with Price Protection or Rights of Return
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Percent of revenue from customers with rights of return or price protection	20.00%	24.00%	22.00%	24.00%

Acquisition of Inotera (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 06, 2016	Mar. 02, 2017	Mar. 03, 2016	Mar. 02, 2017	Mar. 03, 2016	Sep. 01, 2016	Dec. 05, 2016
Acquisition of Inotera
Gain on difference between fair value and carrying value of pre-acquisition equity interests in Inotera		$ 71	$ 0	$ 71	$ 0
Consideration
Payments attributed to intercompany balances with Inotera				361	0
Assets acquired and liabilities assumed
Goodwill		1,190		1,190		$ 104
Unaudited Pro Forma Financial Information
Net sales		4,648	2,927	8,613	6,272
Net income (loss)		890	(196)	1,080	(48)
Net income (loss) attributable to Micron		$ 890	$ (197)	$ 1,080	$ (49)
Earnings (loss) per share, basic (in dollars per share)		$ 0.81	$ (0.18)	$ 0.98	$ (0.04)
Earnings (loss) per share, diluted (in dollars per share)		$ 0.77	$ (0.18)	$ 0.93	$ (0.04)
Inotera \| Nanya and certain of its affiliates
Acquisition of Inotera
Percentage interest in Inotera held by Nanya immediately prior to acquisition (in hundredths)							32.00%
Inotera
Acquisition of Inotera
Ownership interest in Inotera immediately prior to acquisition							33.00%
Percentage of Inotera voting interests acquired	67.00%
Micron Shares
Cash proceeds received from issuance of Micron Shares to Nanya	$ 986
Consideration
Cash paid for Inotera Acquisition	4,099
Less cash received from selling Micron Shares	(986)
Net cash paid for Inotera Acquisition	3,113
Fair value of our previously-held equity interest in Inotera	1,441
Fair value of Micron Shares exchanged for Inotera shares	995
Other	3
Payments attributed to intercompany balances with Inotera	(361)
Total fair value of consideration for Inotera including previously held equity interests	5,191
Assets acquired and liabilities assumed
Cash and equivalents	118
Inventories	285
Other current assets	27
Property, plant, and equipment	3,781
Deferred tax assets	74
Goodwill	1,086
Other noncurrent assets	117
Accounts payable and accrued expenses	(232)
Long-term debt	(56)
Other noncurrent liabilities	(9)
Total assets acquired and liabilities assumed, including goodwill	$ 5,191
Inotera \| Private Placement
Micron Shares
Number of Micron Shares issued to Nanya as consideration for Inotera shares not already owned (in shares)	58
Cash proceeds received from issuance of Micron Shares to Nanya	$ 986
Consideration
Less cash received from selling Micron Shares	(986)
Inotera \| Private Placement \| Level 2
Micron Shares
Discount for lack of transferability on Micron Shares issued to Nanya	$ 81
Inotera \| Selling, general, and administrative
Acquisition of Inotera
Transaction costs incurred in connection with acquisition of Inotera				$ 13		$ 3
Inotera \| Other non-operating income expense, net \| Level 3
Acquisition of Inotera
Gain on difference between fair value and carrying value of pre-acquisition equity interests in Inotera		$ 71

Cash and Investments (Details) - USD ($)

3 Months Ended

6 Months Ended

Mar. 02, 2017

Mar. 03, 2016

Mar. 02, 2017

Mar. 03, 2016

Sep. 01, 2016

Sep. 03, 2015

Schedule of Available-for-sale Securities [Line Items]

$ 3,633,000,000

$ 3,078,000,000

$ 3,633,000,000

$ 3,078,000,000

$ 4,140,000,000

$ 2,287,000,000

265,000,000

258,000,000

^[1]

589,000,000

414,000,000

Available-for-sale Securities, Gross Realized Gain (Loss), Disclosures [Abstract]

4,487,000,000

4,812,000,000

Proceeds from sales of available-for-sale securities

36,000,000

$ 585,000,000

548,000,000

$ 992,000,000

Available-for-sale securities in an unrealized loss position for longer than twelve months

Available-for-sale Securities, Gross Realized Gain (Loss), Disclosures [Abstract]

Noncurrent restricted cash and cash equivalents

97,000,000

$ 97,000,000

122,000,000

Minimum

Schedule of Available-for-sale Securities [Line Items]

Long-term marketable investments, general maturities (in years)

1 year

Maximum

Schedule of Available-for-sale Securities [Line Items]

Long-term marketable investments, general maturities (in years)

4 years

Cash

Schedule of Available-for-sale Securities [Line Items]

2,744,000,000

$ 2,744,000,000

2,258,000,000

Money market funds | Level 1

2,744,000,000

2,258,000,000

Schedule of Available-for-sale Securities [Line Items]

^[2]

306,000,000

1,507,000,000

^[2]

^[1],[2]

Certificates of deposit | Level 2

^[2]

306,000,000

1,507,000,000

Schedule of Available-for-sale Securities [Line Items]

^[3]

456,000,000

373,000,000

^[3]

9,000,000

33,000,000

^[1],[3]

8,000,000

Corporate bonds | Level 2

^[3]

473,000,000

406,000,000

Schedule of Available-for-sale Securities [Line Items]

^[3]

13,000,000

^[3]

120,000,000

142,000,000

^[1],[3]

300,000,000

235,000,000

Government securities | Level 2

^[3]

433,000,000

377,000,000

Schedule of Available-for-sale Securities [Line Items]

^[3]

24,000,000

2,000,000

^[3]

76,000,000

62,000,000

^[1],[3]

106,000,000

82,000,000

Asset-backed securities | Level 2

^[3]

206,000,000

146,000,000

Schedule of Available-for-sale Securities [Line Items]

^[3]

^[3]

2,000,000

12,000,000

^[1],[3]

175,000,000

97,000,000

Commercial paper | Level 2

^[3]

177,000,000

109,000,000

Schedule of Available-for-sale Securities [Line Items]

^[3]

90,000,000

^[3]

58,000,000

9,000,000

^[1],[3]

Movement in Property, Plant and Equipment [Roll Forward]

^[3]

$ 148,000,000

$ 9,000,000

[1]	The maturities of long-term marketable investments range from one to four years.
[2]	The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets.
[3]	The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from these pricing services. No adjustments were made to such pricing information as of March 2, 2017.

Receivables (Details) - USD ($) $ in Millions	Mar. 02, 2017	Sep. 01, 2016
Current Receivables [Abstract]
Trade receivables	$ 2,528	$ 1,765
Income and other taxes	125	119
Other	238	184
Receivables	$ 2,891	$ 2,068

Inventories (Details) - USD ($) $ in Millions	Mar. 02, 2017	Sep. 01, 2016
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Finished goods	$ 862	$ 899
Work in process	1,833	1,761
Raw materials and supplies	305	229
Inventories	$ 3,000	$ 2,889

Property, Plant, and Equipment (Details) - USD ($)
$ in Millions

3 Months Ended

6 Months Ended

Mar. 02, 2017

Mar. 03, 2016

Mar. 02, 2017

Mar. 03, 2016

Sep. 01, 2016

Property, plant and equipment, gross beginning balance

$ 33,605

Property, plant and equipment, retirements and other

6,153

(267)

Property, plant and equipment, gross ending balance

$ 39,491

39,491

Movement in Accumulated Depreciation, Depletion and Amortization, Property, Plant and Equipment [Roll Forward]

Accumulated depreciation beginning balance

(18,919)

Accumulated depreciation, addition due to current period depreciation expense

(1,720)

Retirements and other changes to accumulated depreciation

246

Accumulated depreciation ending balance

(20,393)

Movement in Property, Plant and Equipment, Net [Roll Forward]

Property, plant and equipment, net affect of additions and depreciation expense

19,098

$ 14,686

4,433

Property, plant and equipment, net affect retirements and other adjustments

(21)

Depreciation [Abstract]

Depreciation expense

976

$ 745

1,720

$ 1,450

Land

Movement in Property, Plant and Equipment [Roll Forward]

Property, plant and equipment, gross beginning balance

145

Property, plant and equipment, retirements and other

205

(2)

Property, plant and equipment, gross ending balance

348

Buildings

Movement in Property, Plant and Equipment [Roll Forward]

Property, plant and equipment, gross beginning balance

6,653

Property, plant and equipment, retirements and other

785

(12)

Property, plant and equipment, gross ending balance

7,426

Equipment

Movement in Property, Plant and Equipment [Roll Forward]

Property, plant and equipment, gross beginning balance

^[1]

25,910

Property, plant and equipment, retirements and other

5,170

(254)

Property, plant and equipment, gross ending balance

^[1]

30,826

Equipment | Equipment not placed into service

Movement in Property, Plant and Equipment [Roll Forward]

Property, plant and equipment, gross beginning balance

1,470

Property, plant and equipment, gross ending balance

956

Construction in progress

Movement in Property, Plant and Equipment [Roll Forward]

Property, plant and equipment, gross beginning balance

^[2]

475

Property, Plant and Equipment, Net transfers out of CIP

(18)

Property, plant and equipment, retirements and other

Property, plant and equipment, gross ending balance

^[2]

460

Software

Movement in Property, Plant and Equipment [Roll Forward]

Property, plant and equipment, gross beginning balance

422

Property, plant and equipment, retirements and other

(2)

Property, plant and equipment, gross ending balance

$ 431

[1]	Included costs related to equipment not placed into service of $956 million and $1.47 billion as of March 2, 2017 and September 1, 2016, respectively.
[2]	Included building-related construction and tool installation costs for assets not placed into service.

Property, Plant, and Equipment Change in Useful Lives (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended		9 Months Ended
	Mar. 02, 2017	Dec. 01, 2016	Sep. 01, 2016	Mar. 03, 2016	Mar. 02, 2017	Mar. 03, 2016	Jun. 02, 2016
Change in Accounting Estimate [Line Items]
Decrease in depreciation from change in useful lives	$ 976			$ 745	$ 1,720	$ 1,450
Equipment \| DRAM \| Service Life
Change in Accounting Estimate [Line Items]
Useful life of equipment			7 years				5 years
Scenario, Adjustment \| Equipment \| DRAM \| Service Life
Change in Accounting Estimate [Line Items]
Decrease in depreciation from change in useful lives	$ (100)	$ (100)

Equity Method Investments (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
Equity Method Investments (Details) - USD ($) $ in Millions	Mar. 02, 2017	Dec. 01, 2016	Mar. 03, 2016	Mar. 02, 2017	Mar. 03, 2016	Dec. 06, 2016	Sep. 01, 2016
Schedule of Equity Method Investments [Line Items]
Investment Balance	$ 38			$ 38			$ 1,364
Equity in net income (loss) of equity method investees, net of tax	7		$ 5	5	$ 64
Inotera
Schedule of Equity Method Investments [Line Items]
Investment Balance	$ 0			$ 0			$ 1,314
Ownership Percentage (in hundredths)	0.00%			0.00%			33.00%
Equity in net income (loss) of equity method investees, net of tax	$ 0		2	$ 9	54
Tera Probe
Schedule of Equity Method Investments [Line Items]
Investment Balance	$ 23			$ 23			$ 36
Ownership Percentage (in hundredths)	40.00%			40.00%			40.00%
Equity in net income (loss) of equity method investees, net of tax	$ 7		3	$ (5)	6
Difference between cost of Tera Probe investment and underlying equity	47			$ 47
Weighted-average period for remaining Tera Probe amortization (in years)				7 years
Tera Probe \| Level 1
Schedule of Equity Method Investments [Line Items]
Other than temporary impairment in Tera Probe		$ 16
Other
Schedule of Equity Method Investments [Line Items]
Investment Balance	15			$ 15			$ 14
Equity in net income (loss) of equity method investees, net of tax	$ 0		$ 0	$ 1	$ 4
Inotera
Schedule of Equity Method Investments [Line Items]
Percentage of Inotera voting interests acquired						67.00%

Equity Method Investments - 2 (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended
	Mar. 02, 2017	Dec. 01, 2016	Mar. 03, 2016	Mar. 02, 2017	Mar. 03, 2016
Inotera \| Inventories \| DRAM
Related Party Transaction [Line Items]
Purchases of DRAM products from Inotera		$ 504	$ 326		$ 705
Tera Probe
Related Party Transaction [Line Items]
Related party purchases from Tera Probe	$ 16		$ 18	$ 32	$ 39

Intangible Assets and Goodwill - Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 02, 2017	Mar. 03, 2016	Mar. 02, 2017	Mar. 03, 2016	Sep. 01, 2016
Amortizing assets [Line Items]
Amortizing assets, Gross Amount	$ 756		$ 756		$ 758
Accumulated Amortization	(439)		(439)		(402)
Amortization expense for intangible assets	27	$ 29	54	$ 60
Annual amortization expense for intangible assets [Abstract]
Remainder of 2017	55		55
2018	95		95
2019	47		47
2020	31		31
2021	27		27
Intangible Assets, Net (Including Goodwill) [Abstract]
Total intangible assets, Gross Amount (excluding goodwill)	864		864		866
Goodwill	1,190		1,190		104
In-process R&D
Non-amortizing assets [Line Items]
Non-amortizing assets, Gross Amount	108		108		108
Product and process technology
Amortizing assets [Line Items]
Amortizing assets, Gross Amount	755		755		757
Accumulated Amortization	(439)		(439)		(402)
Product and process technology intangible asset capitalized during period			$ 14	$ 16
Product and process technology intangible asset capitalized during period, weighted-average useful lives (in years)			10 years	10 years
Other
Amortizing assets [Line Items]
Amortizing assets, Gross Amount	1		$ 1		1
Accumulated Amortization	$ 0		$ 0		$ 0

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	Mar. 02, 2017	Sep. 01, 2016
Accounts payable	$ 1,380	$ 1,186
Property, plant, and equipment payables	1,378	1,649
Salaries, wages, and benefits	447	289
Customer advances	153	132
Income and other taxes	117	41
Related party payables	7	273
Other	319	309
Total accounts payable and accrued expenses	$ 3,801	3,879
Inotera \| DRAM
Related party payables		$ 266

Debt - Schedule of Long-term Debt (Details)
$ in Millions, $ in Billions

2 Months Ended

3 Months Ended

4 Months Ended

6 Months Ended

Dec. 06, 2016

USD ($)

payment

Dec. 06, 2016

TWD ($)

payment

Dec. 02, 2016

USD ($)

Oct. 26, 2016

Mar. 02, 2017

USD ($)

payment

Mar. 02, 2017

USD ($)

payment

Mar. 02, 2017

USD ($)

payment

Mar. 27, 2017

USD ($)

Mar. 02, 2017

TWD ($)

payment

Sep. 01, 2016

USD ($)

$ 1,117

$ 756

11,308

9,154

Reorganization obligation

12,425

9,910

148

189

446

680

$ 594

869

Capital lease obligations

6.52%

$ 349

380

914

1,026

1,263

$ 1,263

1,263

1,406

Capital lease obligation incurred

$ 82

$ 133

Capital lease obligations | Weighted Average

3.42%

Weighted average effective interest rate incurred in period (in thousandths)

2.90%

Weighted-average expected capital lease term

7 years

Debt instrument, original term

7 years

Secured Debt | 2021 MSAC senior secured term loan

$ 0

445

$ 445

3.464%

3.87%

Weighted-average expected capital lease term

5 years

Debt instrument, original term

5 years

Line of Credit Facility, Maximum Borrowing Capacity

$ 800

Draw on facility agreement

$ 450

Debt instruments number of periodic payments | payment

Secured Debt | 2021 MSAC senior secured term loan | Maximum

Debt Instrument, covenant, ratio of debt to fair value of equipment

0.8

Secured Debt | 2021 MSAC senior secured term loan | LIBOR

Debt Instrument Variable Reference Rate Period 1

3 months

2.40%

Secured Debt | 2021 MSTW senior secured term loan

2.40%

$ 0

2,584

$ 2,584

2.852%

3.02%

Debt Instrument, Covenant Compliance, Penalty Interest Percent

0.25%

Secured Debt | 2021 MSTW senior secured term loan | Minimum | Debt Covenant Period 2017

Secured Debt | 2021 MSTW senior secured term loan | Minimum | Debt Covenant Period 2017_2018 | Micron Semiconductor Taiwan Co. Ltd.

$ 9,000

Secured Debt | 2021 MSTW senior secured term loan | Minimum | Debt Covenant Period 2019_2020 | Micron Semiconductor Taiwan Co. Ltd.

$ 4.0

Secured Debt | 2021 MSTW senior secured term loan | Minimum | Debt Covenant Period 2021 | Micron Semiconductor Taiwan Co. Ltd.

6.5

Secured Debt | 2021 MSTW senior secured term loan | Minimum | Debt Covenant Period 2018_2019

$ 12.0

Secured Debt | 2021 MSTW senior secured term loan | Minimum | Debt Covenant Period 2020_2021

12,500

Secured Debt | 2021 MSTW senior secured term loan | Maximum | Debt Covenant Period 2017

$ 16,500

Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA

3.5

Secured Debt | 2021 MSTW senior secured term loan | Maximum | Debt Covenant Period 2017_2018 | Micron Semiconductor Taiwan Co. Ltd.

Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA

5.5

Secured Debt | 2021 MSTW senior secured term loan | Maximum | Debt Covenant Period 2019_2021 | Micron Semiconductor Taiwan Co. Ltd.

Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA

4.5

Secured Debt | 2021 MSTW senior secured term loan | Maximum | Debt Covenant Period 2018_2019

Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA

3.0

Secured Debt | 2021 MSTW senior secured term loan | Maximum | Debt Covenant Period 2020_2021

Debt Instrument, Covenant, Ratio Of Total Debt To EBITDA

2.5

Secured Debt | 2021 MSTW senior secured term loan | Inotera

Weighted-average expected capital lease term

5 years

Debt instrument, original term

5 years

Debt instruments number of periodic payments | payment

Secured Debt | 2021 MSTW senior secured term loan | Inotera | Micron Semiconductor Taiwan Co. Ltd. | Inotera Stock

2021 Term loan draw

$ 2,500

$ 80.0

Percentage of post-acquisition Inotera shares subject to collateralization

82.00%

Secured Debt | 2021 MSTW senior secured term loan | Inotera | Minimum

Debt Instrument Variable Reference Rate Period 1

3 months

Secured Debt | 2021 MSTW senior secured term loan | Inotera | Maximum

Debt Instrument Variable Reference Rate Period 1

6 months

Secured Debt | 2021 MSTW senior secured term loan | Inotera | Taipei Interbank Offered Rate TAIBOR

2.05%

Secured Debt | 2022 senior secured term loan B

2.05%

$ 5

728

730

$ 733

735

4.54%

Secured Debt | 2022 senior secured term loan B | Variable Interest Rate Base Rate Option

4.95%

5.00%

2.75%

Secured Debt | 2022 senior secured term loan B | LIBOR | Variable Interest Rate LIBOR Rate Option

5.00%

2.75%

6.00%

3.75%

Secured Debt | 2023 senior secured notes

6.00%

3.75%

$ 0

1,238

1,237

$ 1,238

1,237

7.50%

Corporate bonds | Subsequent Event

7.69%

Tender Offers

Cash tender offer for the repurchase of debt

$ 1,000

Corporate bonds | 2022 senior notes

$ 0

591

590

$ 591

590

5.875%

Corporate bonds | 2023 senior notes

6.14%

$ 0

990

$ 990

990

5.25%

Corporate bonds | 2024 senior notes

5.43%

$ 0

546

$ 546

546

5.25%

Corporate bonds | 2025 senior notes

5.38%

$ 0

1,140

1,139

$ 1,140

1,139

5.50%

Corporate bonds | 2026 senior notes

5.56%

$ 0

446

$ 446

446

5.625%

5.73%

Convertible Debt

Conversion rights, threshold percentage of applicable conversion price (in hundredths)

130.00%

Conversion rights, minimum number of trading days (in days) | d

Conversion rights, consecutive trading period (in days)

30 days

Convertible Senior Notes

Conversion Value in Excess of Principal

$ 1,210

Convertible Debt | 2032C convertible senior notes

$ 0

^[1]

$ 0

^[1]

207

^[1]

207

^[1]

207

^[1]

204

$ 207

^[1]

$ 207

^[1]

$ 207

^[1]

204

2.375%

Convertible Debt | 2032D convertible senior notes

5.95%

$ 0

^[1]

$ 0

^[1]

$ 0

^[1]

156

^[1]

156

^[1]

156

^[1]

154

$ 156

^[1]

$ 156

^[1]

$ 156

^[1]

154

3.125%

Convertible Debt | 2033E convertible senior notes

6.33%

^[1]

$ 171

^[1]

168

^[1]

$ 171

168

1.625%

Convertible Debt | 2033F convertible senior notes

4.50%

^[1]

$ 274

^[1]

271

^[1]

$ 274

271

2.125%

Convertible Debt | 2043G convertible senior notes

4.93%

$ 0

664

657

$ 664

657

3.00%

6.76%

Other notes payable

$ 170

182

213

316

Other notes payable | Weighted Average

$ 383

$ 498

2.189%

2.59%

[1]

Contingencies (Details) - Pending Litigation $ in Millions	6 Months Ended
Contingencies (Details) - Pending Litigation $ in Millions	Mar. 02, 2017 USD ($) patent
Qimonda AG Inotera Share Purchase Proceedings
Loss Contingencies [Line Items]
Percentage of total Inotera shares subject to litigation	18.00%
Loss contingency, judgment under appeal \| $	$ 1
Patent Matters \| Elm 3DS Innovations, LLC
Loss Contingencies [Line Items]
Number of patents allegedly infringed	13
Patent Matters \| Innovative Memory Solutions, Inc.
Loss Contingencies [Line Items]
Number of patents allegedly infringed	8
Patent Matters \| Harvard University
Loss Contingencies [Line Items]
Number of patents allegedly infringed	2

Redeemable Convertible Notes (Details) - USD ($) $ in Millions	Mar. 02, 2017	Sep. 01, 2016
Debt Instrument [Line Items]
Redeemable convertible notes	$ 28	$ 0
2033E and 2033F convertible senior notes
Debt Instrument [Line Items]
Redeemable convertible notes	$ 28

Equity - Treasury Stock (Details) - Inotera shares in Millions, $ in Millions	Dec. 06, 2016 USD ($) shares
Class of Stock [Line Items]
Cash proceeds received from issuance of Micron Shares to Nanya (treasury shares component)	$ 986
Private Placement
Class of Stock [Line Items]
Number of Micron Shares issued to Nanya as consideration for Inotera shares not already owned (in shares) \| shares	58
Cash proceeds received from issuance of Micron Shares to Nanya (treasury shares component)	$ 986
Private Placement \| Treasury Stock, Common
Class of Stock [Line Items]
Cash proceeds received from issuance of Micron Shares to Nanya (treasury shares component)	$ 925
Treasury shares included in sale of shares to Nanya \| shares	54
Decrease in treasury stock as a result of the issuance of shares to Nanya	$ 1,030
Decrease in retained earnings due to reissuance of treasury shares at price lower than purchase price	$ 104

Equity - Outstanding Capped Calls (Details) - USD ($) shares in Millions	6 Months Ended
	Mar. 02, 2017	Sep. 01, 2016
Option Indexed to Issuer's Equity [Line Items]
Treasury Stock, held (in shares)	4	54
Call Option \| Purchased options \| Minimum
Option Indexed to Issuer's Equity [Line Items]
Range of value at expiration of outstanding capped calls	$ 0
Call Option \| Purchased options \| Maximum
Option Indexed to Issuer's Equity [Line Items]
Range of value at expiration of outstanding capped calls	$ 652,000,000
Call Option \| Purchased options \| 2032C and 2032D convertible senior notes
Option Indexed to Issuer's Equity [Line Items]
Capped call settlement shares received	4
Capped call settlement, dollar value of shares received	$ 67,000,000
Treasury Stock, held (in shares)	4

Equity - Shareholder Rights Agreement (Details)	Mar. 02, 2017 right_per_share
Equity [Abstract]
Shareholder Rights Plan, Purchase Discount Rights Received (per share)	1

Equity - NCI and Consolidated VIE Disclosures (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 02, 2017	Mar. 03, 2016	Mar. 02, 2017	Mar. 03, 2016	Sep. 01, 2016
Variable Interest Entity [Line Items]
Noncontrolling interests in subsidiaries	$ 848		$ 848		$ 848
Noncontrolling Interest Items [Abstract]
R and D expenses reduced by reimbursements from Intel	473	$ 403	943	$ 824
Net sales	4,648	2,934	8,618	6,284
Intel \| Non-Volatile Memory \| Non-Trade Sales
Noncontrolling Interest Items [Abstract]
Net sales	158	126	281	252
Intel \| Collaborative Arrangement Process Design and Process Development
Noncontrolling Interest Items [Abstract]
R and D expenses reduced by reimbursements from Intel	(59)	$ (53)	(115)	(99)
Other consolidated entities
Variable Interest Entity [Line Items]
Noncontrolling interests in subsidiaries	16		16		16
Variable Interest Entity, Primary Beneficiary \| IM Flash Technologies, LLC
Variable Interest Entity [Line Items]
Noncontrolling interests in subsidiaries	$ 832		$ 832		$ 832
Noncontrolling interest percentage (in hundredths)	49.00%		49.00%		49.00%
Ownership percentage after stock transactions during period (in hundredths)	51.00%		51.00%
Noncontrolling Interest Items [Abstract]
Micron contributions to IMFT				38
Intel contributions to IMFT				$ 37

Equity - Consolidated VIE assets and liabilities (Details) - USD ($)
$ in Millions

Mar. 02, 2017

Sep. 01, 2016

Mar. 03, 2016

Sep. 03, 2015

Assets

$ 3,633

$ 4,140

$ 3,078

$ 2,287

2,891

2,068

3,000

2,889

Other current assets

156

140

Total current assets

9,945

9,495

19,098

14,686

Accounts payable and accrued expenses

391

356

Total assets

32,355

27,540

Liabilities

3,801

3,879

Deferred income

289

200

Total current liabilities

1,117

756

5,207

4,835

Other noncurrent liabilities

11,308

9,154

677

623

Total liabilities

17,192

14,612

Variable Interest Entity, Primary Beneficiary | IM Flash Technologies, LLC

Assets

^[1]

^[1]

103

^[1]

102

Other current assets

^[1]

Total current assets

^[1]

305

261

^[1]

1,680

1,792

Accounts payable and accrued expenses

^[1]

Total assets

^[1]

2,027

2,103

Liabilities

^[1]

151

175

Deferred income

^[1]

Total current liabilities

^[1]

^[1]

173

198

Other noncurrent liabilities

^[1]

^[1]

Total liabilities

^[1]

$ 301

$ 358

[1]	Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.

Equity - Restrictions on Net Assets (Details) $ in Millions	Mar. 02, 2017 USD ($)
MMJ Group
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]
Amount of Restricted Net Assets	$ 3,380
MSTW and Inotera
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]
Amount of Restricted Net Assets	2,800
IM Flash Technologies, LLC
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]
Amount of Restricted Net Assets	894
Cash and Cash Equivalents \| MMJ Group
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]
Amount of Restricted Net Assets	529
Cash and Cash Equivalents \| MSTW and Inotera
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]
Amount of Restricted Net Assets	297
Cash and Cash Equivalents \| IM Flash Technologies, LLC
Restrictions for Consolidated and Unconsolidated Subsidiaries [Abstract]
Amount of Restricted Net Assets	$ 94

Fair Value Measurements - Fair and Carrying Value (Details) - USD ($) $ in Millions	Mar. 02, 2017	Sep. 01, 2016
Fair value disclosure [Line Items]
Carrying Value of Debt	$ 12,425	$ 9,910
Fair Value \| Level 2 \| Notes and MMJ creditor installment payments
Fair value disclosure [Line Items]
Fair value of Notes and MMJ creditor installment payments	10,092	7,257
Fair Value \| Level 2 \| Convertible Notes
Fair value disclosure [Line Items]
Fair value of Convertible notes	3,191	2,408
Carrying Value \| Notes and MMJ creditor installment payments
Fair value disclosure [Line Items]
Carrying Value of Debt	9,690	7,050
Carrying Value \| Convertible Notes
Fair value disclosure [Line Items]
Carrying Value of Debt	$ 1,472	$ 1,454

Derivative Instruments - Fair Values (Details) - Forward Contracts
$ in Millions, ¥ in Billions

6 Months Ended

Mar. 02, 2017

USD ($)

Mar. 02, 2017

JPY (¥)

Sep. 01, 2016

USD ($)

Not Designated as Hedging Instrument

Foreign Currency Cash Flow Hedges [Abstract]

$ 4,193

$ 2,052

General maturity of non-designated currency forward contracts (in days)

8 months

Not Designated as Hedging Instrument | 2017 Reorganization Payment Hedges

Notional Amount Outstanding | ¥

¥ 18

Not Designated as Hedging Instrument | 2018 Reorganization Payment Hedges

Notional Amount Outstanding | ¥

¥ 28

Not Designated as Hedging Instrument | New Taiwan dollar

Not Designated as Hedging Instrument | Yen

$ 2,855

Not Designated as Hedging Instrument | Euro

1,033

1,668

Not Designated as Hedging Instrument | Singapore dollar

151

Not Designated as Hedging Instrument | Other

134

206

Not Designated as Hedging Instrument | Accounts receivable

Not Designated as Hedging Instrument | Accounts receivable | New Taiwan dollar

^[1]

Not Designated as Hedging Instrument | Accounts receivable | Yen

^[1]

Not Designated as Hedging Instrument | Accounts receivable | Euro

^[1]

Not Designated as Hedging Instrument | Accounts receivable | Singapore dollar

^[1]

Not Designated as Hedging Instrument | Accounts receivable | Other

^[1]

Not Designated as Hedging Instrument | Accounts payable and accrued expenses

^[1]

Not Designated as Hedging Instrument | Accounts payable and accrued expenses | New Taiwan dollar

^[2]

(16)

(11)

Not Designated as Hedging Instrument | Accounts payable and accrued expenses | Yen

^[2]

(2)

Not Designated as Hedging Instrument | Accounts payable and accrued expenses | Euro

^[2]

(12)

(10)

Not Designated as Hedging Instrument | Accounts payable and accrued expenses | Singapore dollar

^[2]

(1)

Not Designated as Hedging Instrument | Accounts payable and accrued expenses | Other

^[2]

(1)

Not Designated as Hedging Instrument | Other noncurrent liabilities

^[2]

(1)

Not Designated as Hedging Instrument | Other noncurrent liabilities | New Taiwan dollar

^[3]

(4)

Not Designated as Hedging Instrument | Other noncurrent liabilities | Yen

^[3]

Not Designated as Hedging Instrument | Other noncurrent liabilities | Euro

^[3]

(4)

Not Designated as Hedging Instrument | Other noncurrent liabilities | Singapore dollar

^[3]

Not Designated as Hedging Instrument | Other noncurrent liabilities | Other

^[3]

Designated as Hedging Instrument | Cash Flow Hedging

^[3]

Foreign Currency Cash Flow Hedges [Abstract]

$ 12

172

General maturity of hedge contracts (in months)

12 months

Designated as Hedging Instrument | Cash Flow Hedging | Yen

Designated as Hedging Instrument | Cash Flow Hedging | Euro

$ 6

107

Designated as Hedging Instrument | Cash Flow Hedging | Accounts receivable

Designated as Hedging Instrument | Cash Flow Hedging | Accounts receivable | Yen

^[1]

Designated as Hedging Instrument | Cash Flow Hedging | Accounts receivable | Euro

^[1]

Designated as Hedging Instrument | Cash Flow Hedging | Accounts payable and accrued expenses

^[1]

Designated as Hedging Instrument | Cash Flow Hedging | Accounts payable and accrued expenses | Yen

^[2]

(2)

Designated as Hedging Instrument | Cash Flow Hedging | Accounts payable and accrued expenses | Euro

^[2]

(1)